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ABSTRACT
Toxoplasma gondii, an obligate intracellular parasite, has the ability to differentiate 
between actively replicating tachyzoites and encysted bradyzoites. Bradyzoites within the 
tissue cysts are resistant to both the immune system and the chemotherapy. They are not 
only responsible for the transmission of the parasites via camivorism, but also the source 
for recrudescence of infection in immunocompromised patients. Molecular mechanisms 
triggering the differentiation between the two forms are not clear. However, studies have 
shown that T.gondii expresses two distinct lactate dehydrogenases (LDH) during its stage 
conversion; LDH1 during the tachyzoite and LDH2 during the bradyzoite stage. LDH2 
shows transcriptional regulation by being exclusively expressed during bradyzoite stage 
that resembles anaerobic condition. Whereas LDH1 transcription is found in both stages 
and indicates a translational suppression of LDH 1 in bradyzoites. Regulatory activities of 
5' and 3 'untranslated region have been reported in other eukaryotic systems indicating 
their role in gene expression. Aim of this study is to investigate the role of upstream and 
downstream sequences of LDH1 in translational suppression and to observe the effect of 
removal of suppression of LDH2 gene on the parasite’s phenotype. For the first part of 
this study, transgenic parasite strains were generated to express GFP under the influence 
of upstream and/or downstream sequence of LDH1. GFP expression and localization was 
measured during both stages of the parasites and was found decreased in bradyzoite 
stage. These results indicates that the upstream and down stream sequences of LDH1 
could be responsible for the lowered GFP expression. Possible effects on phenotype and 
future work are discussed.
m
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CHAPTER 1 
INTRODUCTION
1.1 Toxoplasma gondii
Toxoplasma gondii is an unusually promiscuous intracellular protozoan parasite 
that has the ability to infect virtually any vertebrate. It belongs to phylum Apicomplexa 
and is closely related to other protozoan parasites e.g. Plasmodium and Cryptosporidium 
(Dubey, 1994). Based on its worldwide distribution, T. gondii is the most ubiquitous 
parasite of the vertebrates that infects up to 50% of the human population (Dubey, 1977).
Infection occurs through ingestion of viable tissue-cyst in undercooked meat or by 
contact with the oocysts shed in cat’s feces. Infection in healthy individuals remains 
asymptomatic except for some mild clinical symptoms. However, this infection progress 
to a chronic state without complications, persists for the life time of the host, and remains 
clinically unapparent. On the contrary, primary infection during pregnancy cause trans­
placental transmission of the parasite and can lead to spontaneous abortion or severe 
congenital birth defects such as blindness, mental retardation, and hydro encephalopathy. 
Severity of infection depends on stage of pregnancy (Luft and Remington, 1992). Being 
an opportunistic pathogen, T. gondii, can reactivate the chronic infection in conditions 
where host immune system is compromised e.g. patients receiving cytotoxic 
chemotherapy or with HIV/AIDS. Unrestricted parasite growth leads to severe 
toxoplasmosis in such patients (Luft and Remington, 1988; Mills, 1986). In recent years, 
there has been a dramatic increase in the population of immunocompromised individuals 
and T. gondii can cause intracerebral focal lesions, leading to toxoplasmic encephalitis in 
this group (Wong and Remington, 1993).
1
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Infection in the intermediate host (humans, cattle, birds) involves stage 
conversion between the two asexual forms of T. gondii i.e. rapidly multiplying 
tachyzoites which is responsible for acute toxoplasmosis and slowly dividing bradyzoites 
which is dormant encysted form found predominantly in brain and muscles. Tachyzoites 
are effectively cleared away by host’s immune system (Dubey, 1994) while bradyzoites 
remain protected from immune response for the remaining life span of the host (Soete et 
al., 1993) and act as a source of infection for transmission via camivorism. This stage 
conversion is reversible and is responsible for the reactivation of a chronic infection into 
an acute one during period of lowered immunity (Freyre, 1995). The differentiation of 
these two forms of T. gondii involves morphological and molecular biological changes 
like stage specific antigen expression and alterations in metabolism (Yang and Parmley, 
1997).
Current medicinal regimen (Sulfonamide and pyrimethamine) can effectively 
eliminate the tachyzoites but do not remove chronic bradyzoite stage (Cooper et al., 
1991). No effective treatment is available for chronic toxoplasmosis to date (Boothroyd 
et al., 1997; Black and Boothroyd, 2000). Inability to completely eliminate the infection 
and toxic side effects of the existing drugs represents a critical need for a safer and more 
effective chemotherapeutic agent. Hence we need to decipher more about T.gondii cell 
biology in order to develop new strategies that could help in elimination of parasite 
infection.
2
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1.1.1 Parasite strains and host cells
Toxoplasma gondii can be grown and maintained in virtually any mammalian cell 
type e.g. HeLa, Vero, macrophages, T cells, and human foreskin fibroblast (HFF) 
(Boothroyd et al., 1997; Mavin et al., 2004). Parasites infect monolayer cultures more 
efficiently as compared to suspension cultures, probably because contact and invasion is 
easy in monolayers. HFF are the most commonly used host cells as they give high 
parasite titer with minimal cell debris, and are resistant to metabolic inhibitors e.g. drugs 
used for parasite selection. Being human cells they also provide comparability to clinical 
infections (Roos et al., 1994; Freyre, 1995).
Many T.gondii laboratory strains are used and show differences in their rate of 
replication, virulence, and ability to form cysts. RH strain is easiest to grow both in cell- 
cultures and in animals and most commonly used because of its high virulence, rapid 
replication, and efficient host cell lysis (Sibley and Boothroyd, 1992). However, RH 
strain has weak ability to differentiate into bradyzoite stage or to from tissue cysts. RH is 
also incapable of making gametes in feline hosts (Freyre, 1995). Two other common 
strains are CEP derived from cat (Pfefferkom et al., 1977) and PLK from sheep (Kasper 
and Ware, 1985). PLK strain is capable of producing tissue cysts and is ideal for 
bradyzoite differentiation and development studies. PLK which is a subclone of ME-49 
strain can complete sexual cycle of parasite in feline host. Replication rate of PLK strain, 
however, is much slower than RH strain (Soete et al., 1993; Boothroyd et al. 1997).
3
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1.1.2 Toxoplasma gondii as experimental model for phylum Apicomplexa
Unlike other members of the phylum apicomplexa that are difficult to culture or 
propagate in the laboratory, T. gondii is amenable to genetic manipulations, easy to 
propagate using standard culture procedures and has emerged as a model for studying 
intracellular parasitism. Haploid genome of the parasite during asexual cycle has 
facilitated the generation of loss-of-function mutants (Black and Boothroyd, 1998). Data 
base of T.gondii genome is also well established (http://toxodb.org: Kissinger et al., 
2003).
1.1.3 Genetic manipulations in T.gondii
For the introduction of different forms of nucleic acids, electroporation is one of 
the most efficient mean for T.gondii transformation. Electric pulse generated during 
electroporation is believed to form small pores within the parasite cell membrane and 
facilitates the uptake of plasmid or nucleic acid. Once taken up by the parasites these 
plasmids serve as vehicle for stable or transient gene expression depending on whether it 
integrate into parasite genome or not (Boothroyd et a l, 1995 and Roos et al., 1994).
Stable DNA transformation results in permanent expression of transgenes by 
random or directed integration into the parasite’s genome (Donald and Roos, 1994). 
Episomal vectors are used for stable transformation without integration into the parasite’s 
genome, eliminating the possibility of mutation due to random integration. Several 
strategies have been established for stable expression of transgene. One such stable DNA 
transformation is based on complementation of naturally occurring tryptophan 
auxotrophy in T.gondii. Prototroph was achieved by expressing E.Coli trpB gene
4
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encoding tryptophan synthase that catalyzes formation of tryptophan from supplemented 
indole or serine and eliminates the tryptophan dependency of T.gondii on host cells. 
Efficient T.gondii selection was made by tryptophan-depleted media and cytokines 
(IFNy) treated host cells (Pfefferkom, 1984). Tryptophan starvation was enhanced by 
IFNy treatment. Transforming vector encoding trpB gene integrated into parasite genome 
by non homologous recombination (Sibley et a l, 1994) and the transformants were stable 
in the absence of continued selection.
Transient gene expression, on the other hand, is achieved when a plasmid fails to 
integrate into the parasite genome (Roos et al., 1994). Expression is most efficient when 
it is under the control of T.gondii gene promoters such as ^-tubulin (TUB1), rhoptry 
protein (ROP1), and surface antigen (SAG1) (Roos et a l, 1994; Soldati et al., 1995), 
TUB1 being the strongest and SAG1 being the weakest promoter. Limitations to transient 
expression are short duration of expression and significant variation in the amount of 
genetic material taken up by the cell resulting into heterogenous population. Several 
reporter genes have been successfully used for transient gene expression such as /?- 
galactosidase (lacZ), ^-glucuronidase igus), chloramphenicol acetyltransferase (cat), and 
luciferase. However, cat appears to function more effectively in T.gondii as compare to 
other reporter genes.
Vectors having small sequences of genomic DNA usually integrate by 
nonhomologous or random recombination (Tomavo, 2001; Sibley et al., 1994). 
Transformation vectors based on sequences from dihydrofolate reductase-thymidyle 
synthase gene (DHFR-TS) have been developed for T. gondii genetic transformation 
(Donald and Roos, 1993). DHFR-TS gene was engineered to harbor mutations analogous
5
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to those found in DHFR-TS gene of pyrimethamine-resistant Plasmodium falciparum to 
introduce resistance for pyrimethamine in T.gondii. In more than 5% of the transformed 
parasites, DHFR-TS gene was reported to integrate into parasite genome by non 
homologous recombination. DHFR-TS mini gene has been used by several investigators 
to disrupt non essential genes by insertional mutagenesis (Donald and Roos 1995; Donald 
et al, 1996). Insertion at the hypoxanthineguanins phosphoribosyl transferase (HXGPRT) 
and Uracil phosphoribosyl transferase (UPRT) loci, which code for enzymes of purine 
and pyrimidine salvage pathway respectively, has been successfully generated.
As with transient expression, insertional mutagenesis has its own limitations, 
Such as the function of an essential gene could be compensated due to complementation. 
500-bp sequence has been reported to permit the maintenance of bacterial plasmid as 
episomal DNA (Black and Boothroyd, 1998). This sequence could incorporate into 
vectors bearing fragments of the parasite genome and vectors can replicate autonomously 
with in T.gondii. On the other hand, Pyrimethamine resistant parasites pose a serious 
hazard because antifolates are used for the treatment of acute toxoplasmosis. Moreover, 
resistant strains should not be passed through a feline host to prevent the formation of 
oocysts having pyrimethamine resistance. Alternative selectable markers such as 
expression of cat that mediates CAT resistance (Kim et al., 1993) expression of ble that 
mediates bleomycin resistance (Perez et al., 1989) and complementation of tryptophan 
auxotrophy using trpB (Sibley et al., 1994) are available, however they exhibit low 
transformation frequency as compare to expression of dhfr that mediates pyrimethamine 
resistance.
6
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Bleomycin resistance has been used as a selectable marker in T.gondii. ble 
resistance gene encodes a small acidic protein BLE which binds to the bleomycin family 
of glycopeptide antibiotic with strong affinity (1:1 complex) and prevents toxicity. Tn5 
ble from Tn5 transposon (Messina et al., 1995) and Sh ble from Streptoallateichus 
hindustanus (Soldati et al., 1995) have been used to express BLE in T.gondii. Bleomycin 
provides efficient selection for extracellular tachyzoites, but has minimal effects on 
intracellular parasites thus selection is repeated twice to prevent leakiness. Also higher 
concentration of the drug can not be used because of its mutagenic effects.
Two non-essential enzymes of nucleotide salvage pathway are also used as 
selectable markers for T. gondii transformation (Donald and Roos, 1994). These enzymes 
are Hypoxanthine-xanthine-guanine phosphoribosyl trasnferase (HXGPRT) that is 
essential for purine salvage and Uracil phosphoribosyl trasnferase (UPRT) that is 
important to pyrimidine salvage. HXGPRT has been used to select the transgenic parasite 
strains during this study. This enzyme catalyzes the conversion of xanthine to xanthine 
monophosphate (XMP), which is then converted to guanine monophosphate (GMP). 
XMP can also be synthesized from inosine monophosphate (IMP) by the enzyme IMP- 
dehydrogenase, in the absence of the substrate i.e. xanthine or the enzyme HXGPRT. The 
drug mycophenolic acid (MPA) can inhibit IMP-dehydrogenase enzyme and prevents the 
conversion of xanthine to XMP and subsequently to GMP.
7
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Figure 1.1 
Purine salvage pathway
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Figure 1.1 Purine salvage pathway. This pathway is important for DNA and 
RNA synthesis. HXGPRT deleted parasite strain is unable to synthesize GMP from 
guanine or hypoxanthine. Selection is made by the drug MPA which inhibits IMPDH 
enzyme. Parasites having HXGPRT as selectable marker would be able to synthesize 
GMP using xanthine as a substrate.
8
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HXGPRT deletion mutant (PLKAHX) was used in this study for the generation of 
transgenic parasites. When PLKAHX parasites were transformed with the plasmid that 
expresses the HXGPRT gene, the selection of transgenic parasites was carried out by 
supplementing the medium with MPA and xanthine. Parental strain is unable to use 
xanthine as a substrate due to deletion of HXGPRT gene. Other route of xanthine 
formation i.e. from IMP to XMP is also blocked due to inhibition of IMP-dehydrogenase 
by the drug MPA. On the contrary, transgenic parasites can use xanthine due to the 
plasmid insertion that has HXGPRT gene.
1.1.4 Sexual and asexual life cycle of T.gondii
Toxoplasma gondii has the ability to infect and replicate in virtually any nucleated 
mammalian or avian cell (Dubey, 1998). T.gondii life cycle is divided into two phases i.e. 
sexual and asexual phase. Sexual cycle exclusively occurs in feline intestinal epithelia, 
with the cat being a definitive host (Frenkel, 1973). This phase begins when a cat ingests 
infected intermediate hosts e.g. rats and birds that have encysted parasites present in their 
tissues (Dubey, 1994; Soete et al., 1993). Bradyzoites are released from the cyst in the 
small intestine and undergo sexual reproduction. The differentiation of bradyzoites into 
micro and macro gametes and later fusion of these gametes results in the formation of 
oocyst. The oocyst later develops a thick impermeable cyst wall and excreted in the feces 
(Soete et al., 1993). Upon exposure to atmosphere, each oocyst undergoes sporulation 
producing eight sporozoites. The mature haploid oocyst is very stable and remains 
infectious for months in cold and dry climates (Dubey, 1994).
9
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Figure 1.2 
Toxoplasma gondii Life cycle
H 'tJ  n n  -b lo o d ed  
interm ediate
fe lin e
bradvzoite
I ! 2 
¥
tachyzoite 7
¥
nocysl
gam ete
4
asexual sexual
(Figure adapted from Boothroyd et al., 1997)
Figure 1.2 Asexual cycle occurs in large number of warm blooded animals. 
Asexual phase involves two forms of parasite i.e. tachygoites and bradyzoites (1, 2). 
Environmental factors especially the host immune response determines the balance 
between the two forms: strong immune response results in encystation whereas 
reactivation results upon lowered immune response. Transmission within asexual phase 
occurs through ingestion of meat infected with encysted bradyzoites (3). Asexual cycle 
involves gametogenesis and fertilization in gut epithelium of feline host (4). 
Transmission within the sexual phase is by ingestion of oocysts in feaces (5). Crossover 
between the two cycles (6, 7) results from accidental ingestion of the mature oocyst or 
bradyzoite infected meat.
10
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The asexual life cycle begins with the ingestion of either sporulated oocysts from 
cat’s feces or viable tissue cysts in raw or undercooked meat. Ingested cysts are ruptured 
as they pass through the digestive tract and results in bradyzoite release. Released 
bradyzoites then infect the epithelium of the intestinal lumen and differentiate back to 
actively dividing tachyzoite form, enters the macrophages for the dissemination through 
out the body, and complete the asexual phase of the life cycle. The immune response 
forces the tachyzoites to shift to the encysted bardyzoites that persist for the remaining 
life span of the host (Dubey, 1994; Soete et al., 1993).
1.1.4.1 Stages of asexual life cycle
The asexual phase of T.gondii life cycle consists of two distinct stages of growth 
i.e. tachyzoite stage or bradyzoite stage. Tachyzoite have an approximate length of 5pm 
and width of 2pm (Smith, 1995) and represents rapidly growing form of parasite that is 
found during acute phase of toxoplasmosis. The first step of infection is parasite 
attachment to the host cell which leads to invasion into parasitophorous vacuole (PV). 
Precise origin o f the vacuole is not known yet. However, this invasion process involves 
clearing of rhoptries (specialized structure located at the apical end of parasite), and 
secretion from dense granules (Carruthers and Sibley, 1997). Unlike many other 
Apicomplexan parasites that replicate multiple times before assembly of daughter cells, 
toxoplasma replicates by endodyogeny i.e. produce two daughter cells in each division. 
In a given vacuole parasites divide synchronously and number of tachyzoites in any 
vacuole is always a power of two. With a generation time of 6-8 hours (in vitro) 
tachyzoites keep replicating with in the cell until they rupture the host cell to infect
11
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neighboring cells (Radke and White, 1998). Parasite exit is facilitated by a twisting 
motility. Ionic changes in host cell membrane due to mechanical strain from growing 
parasitophorous vacuole could induce parasite exit (Endo et al., 1987; Endo and Yatiga, 
1990).
Tachyzoites differentiate into bradyzoites that represent slowly dividing form 
capable of making tissue cyst and appears 7-10 days after infection. These cysts are 
found predominantly in the central nervous system and muscles where they reside for the 
life of the host. Formation of tissue cysts throughout the body defines the chronic stage of 
asexual life cycle. Bradyzoites can be distinguished from tachyzoites by the difference in 
their ultra structure. Bradyzoites accumulates numerous amylopectin granules, have 
increased number of micronemes, have electron dense rhoptries and have their nucleus 
located posteriorly. Tachyzoites, on the other hand normally lack amylopectin granules, 
have fewer micronemes and the nucleus is centrally located (Ferguson and Hutchison 
1987; Matsukayashi and Akao 1963; Dubey, 1993). The host-parasite relationship is also 
different for both. Tachyzoites proliferates with in a parasitophorous vacuole that has a 
single unit membrane and a tubular network is formed from the invaginations of the 
membrane into the vacuole. Bradyzoites, on the contrary, develop with in the cyst that is 
surrounded by a cyst-wall. The differentiation of tachyzoites to bradyzoites occurs when 
the immune system attacks in order to eliminate the proliferating tachyzoites.
Toxoplasma gondii not only modifies its morphology, but presumably its 
metabolism also during stage conversion in order to adapt to the environmental changes. 
Mechanism of stage conversion between two stages of T. gondii as well as factors 
regulating the conversion is not fully understood. Stage specific gene product has been
12
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used as a marker to understand the kinetics of stage conversion both in vitro and in vivo 
models (Burge et al., 1988; Prince et al., 1990; Gazzinelli et al., 1993; Bohne et al 1994; 
and Soete et al., 1994). Multiple factors of both host and parasite origin are most likely 
responsible for stage conversion. Recent studies have shown that small population of 
T.gondii undergoes spontaneous stage conversion in vitro (Tomavo et al., 1991; Soete et 
al., 1993). The percentage of bradyzoites in the population can be increased by altering 
the pH, adding cytokines such as IFN-y, and treating with mitochondrial inhibitors like 
antimycinA (Bohne et al., 1993; Soete et al., 1994). Production of nitric oxide from 
activated macrophages has been suggested to induce conversion to bradyzoite in vivo 
possibly by interfering with parasite electron transport system (Bohne et al., 1993; 1994). 
By altering the parasite mitochondrial function such as energy production, the host tries 
to control parasite proliferation. In response to host action, parasite transforms into slow 
replicating and less energy-consuming stage to maintain its viability. It is also well 
established that high amount of DNA damage can inhibit replication and delay the entry 
of cell into mitosis (Nasmyth, 1996). Immunological and environmental stresses involved 
in T.gondii differentiation could cause increased DNA damage/repair and result in slow
i
replication of encysted bradyzoites. DNA damage may not be the only reason moreover it 
could be the result of nutrient deprivation as a form of stress. Parasites have been 
reported to express stage specific proteins e.g. surface antigens or enzymes, which are 
probably required for the adaptation (Tomavo et al., 1991; Yang and Parmley, 1995; 
Yang and Parmley, 1997; Dzierszinski, 1999). Molecular cloning of the genes encoding 
stage specific enzymes is important and could be helpful in investigating the molecular 
mechanics involved in T. gondii stage conversion from tachyzoite to bradyzoite.
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1.1.4.2 Stage specific difference in metabolism
Mitochondrial inhibitors such as antimycin A, myxothiazol, and oligomycin have 
been reported to increase the expression of bradyzoite-specific antigens indicating a 
correlation between mitochondrial function and stage conversion (Bohne et al. 1994; 
Tomavo and Boothroyd, 1995). Impaired oxidative phosphorylation due to mitochondrial 
dysfunction induces bradyzoite formation in vitro. Key enzymes of TCA cycle and 
oxidative phosphorylation have been reported to be missing in bradyzoites (Denton et al., 
1996), while three isoenzymes (lactate dehydrogenase, glucose 6-phosphate isomerase, 
and enolase) involved in glycolysis have been reported to express stage specifically 
(Yang and Parmley, 1997: Dzierszinski et al., 1999). These observations suggests that 
tachyzoites use both mitochondria and glycolytic pathway as ATP generating source, 
whereas encysted bradyzoites having impaired mitochondrial oxidative phosphorylation 
mainly rely on anaerobic glycolysis (Fulton and Spooner, 1960; Melo et al., 1992; 
Vercesi et a l, 1998; Pfefferkom and Borotz, 1994).
1.1.4.3 Stage specific isoenzymes
Lactate dehydrogenase (LDH), Enolase (ENO), Glucose 6-phosphate isomerase 
(G6-PI), and phospatidylinositol synthase (PIS) have been reported to express stage 
specifically in T.gondii. Except for phospatidylinositol synthase, all are important 
enzymes for glycolysis. Stage specific expression of LDH, main focus of the present 
study, will be discussed in detail in this section.
Lactate dehydrogenase (L-lactate: oxidoreductase, EC 1.1.1.27) uses NAD+ as a 
coenzyme and catalyzes the interconversion of pyruate to lactate during glycolysis. Gene
14
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encoding tachyzoite LDH has been cloned and named as LDH1 and bradyzoite LDH as 
LDH2. These two LDH genes show 64% nucleotide identity in their coding region and 
both have an intron at the same relative position. Size of the intron is 538nt and 588nt in 
LDH1 and LDH2 respectively. Amino acid sequences of the two LDH proteins share 
71.1% identity. Using RT-PCR, Yang and Parmley (1997) have demonstrated that 
mRNA of LDH1 is found equally in both stages of the T. gondii while mRNA of LDH2 
is only detected in bradyzoite stage. The absence of LDH2 mRNA in tachyzoites suggests 
that LDH2 transcription is suppressed during transition from bradyzoite to tachyzoites. 
These data also suggest that LDH1 is exclusively expressed in tachyzoites. LDH2 
mRNA levels have been reported to increases predominantly when tachyzoite to 
bradyzoite differentiation is induced. LDH2 mRNA stability was not determined during 
the study, thus it is not clear whether this increament in LDH2 mRNA is due to 
transcriptional activation of the LDH2 gene or an increase in mRNA stability.
Yang and Parmley (1997) also demonstrated that LDH1 enzyme is only 
detectable in tachyzoites using two dimensional PAGE. Difference in isoelectric points 
i.e. 5.96 for LDH1 and 7.08 for LDH2 has been exploited to show that only one LDH 
protein is expressed in each stage. The possibility of higher isoelectric point of bradyzoite 
LDH due to tyrosoine phosphorylation was ruled out as it would only make tachyzoite 
LDH more acidic (Cooper et al., 1983). Post-translational modifications that make LDH 
more basic have not been reported yet. These results suggest that two distinct forms of 
LDH proteins are produced in each stage i.e. LDH1 in tachyzoite stage and LDH2 in 
bradyzoite stage. Putative promoter sequences of respective LDHs have been used to 
express CAT reporter construct. Approximately 1500 nt upstream and downstream
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sequence of LDH1 were used for CAT expression. High CAT activity observed in 
tachyzoites was reduced to four fold when parasites were switched to bradyzoite stage. 
Similarly 993 nt upstream and 1750 nt downstream sequence of LDH2 were used for 
CAT expression. No activity was detected during tachyzoite stage while CAT expression 
was increased to forty five fold with the differentiation to bradyzoites. This indicates that 
the production of LDH2 seems to be under transcriptional control due to the appearance 
of LDH2 mRNA only in bradyzoites, while production of LDH1 appears to be under 
translational control as mRNA of LDH 1 is present in both stages but it is translated only 
in tachyzoites. Roos et al., 1997 has also showed that putative LDH2 promoter sequences 
are involved in stage specific LDH2 expression during bradyzoite differentiation. Using 
cNTPase (Nucleotide triphosphatase lacking N-terminal signal) as a reporter they 
demonstrated that the reporter expression is transcriptionally controlled with the stage 
conversion. In conclusion, the process of developmental regulation of the two LDH genes 
appears to be different for each stage. Studies have shown that LDH1 and LDH2 genes 
are found on different chromosomes i.e. LDH1 on chromosome VIII and LDH2 on 
chromosome IX. When the expression of both the LDHs was knocked down using 
dsRNA, growth rate in both the stages varied as compared to parental strain and parasite 
differentiation (in-vitro) was impaired. Tachyzoites were unable to form significant 
number of cysts in vivo, to establish a chronic infection (Fatme Al-Anouti et al., 2004). 
These results indicate that LDH expression is important for T.gondii cell cycle.
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1.2 Eukaryotic gene regulation
Eukaryotic gene expression is primarily controlled at the level o f transcription 
initiation (Lemon and Tijan, 2000). Housekeeping genes are expressed constitutively and 
are shut down in response to extreme environmental condition such as heat shock or 
starvation (Prikkala et al., 2001). Facultative genes, on the contrary are expressed in 
response to specific physiological, hormonal or environmental stimuli (Benecke et al., 
2001). Eukaryotic genes that code for protein are transcribed by RNA polymerase II 
hcloenzyme which is composed of 10-12 proteins (Lee and Young, 2000). All the genes 
that are transcribed by the RNA polymerase have two core promoter elements, the TATA 
box and the initiator sequence. Promoters can not generate significant level of mRNA by 
itself, they determine transcription start site and initiate low or basal level of transcription 
(Kuras and Struhl, 1999). Transcriptional machinery assembles on the promoter which 
serves as a docking site for the transcriptional complex. Most of the proteins that bind to 
basal promoters are ubiquitously expressed and have little regulatory specificity (Lemon 
and Tijan, 2000). These proteins are called general transcription factors. In addition to the 
promoter, some regulatory sequences are also needed for accurate regulation of 
transcription and are usually located upstream of the promoter sequence. For example, 
the consensus sequences of two regulatory elements CCAAT and GGGCGG (called GC 
box) are located 100 base pair upstream of the TATA box. These regulatory sequences 
are found in many eukaryotic genes and were first identified during the promoter studies 
of the gene encoding thymidine kinase in herpes simplex virus. Some regulatory 
sequences known as enhancers are located far from the promoter (could be 10 kbp away) 
and were first described by Walter Schaffner in 1981, during the studies of promoter of
17
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another virus SV40. Activity of enhancer is independent of distance or orientation 
(Blackwood and Kadonaga, 1998). On the contrary, upstream repressor sequences have 
been reported to inhibit transcription when bound to specific factors (Hanna-Rose and 
Hansen, 1996). Inhibition occurs through various mechanisms such as interference in 
activator binding or modification in chromatin structure. The silencer, on the other hand, 
is the DNA sequence that represses promoter activity regardless of its orientation and 
position (Guarente, 1999). In higher eukaryotes a CpG dinucleotide motif is reported to 
be involved in gene silencing through DNA methylation (Antequera and Bird, 1999).
1.2.1 Regulation of transcription by chromatin structure
Eukaryotes maintain and control their huge genetic content by packing DNA into 
nucleosomes (Luger et al., 1974). Packaging of promoter into chromatin is a key 
determinant in transcription initiation (Grunstein, 1997). Studies have shown that 
transcriptional activators are associated with histone acetyl transferase (Wolffe and Pruss, 
1996) while transcriptional repressors are linked with histone deacetylase (Pazin and 
Kadonaga, 1997). Protein complexes named as nucleosome remodeling factors facilitate 
the binding of transcription factors to the DNA. By catalyzing the histone octamer along 
the DNA, they reposition the nucleosome and help binding of transcription factors to the 
DNA. DNA methylation at cytosine residues that precedes Guanine (CpG dinucleotide) is 
associated with reduced transcription. A protein MeCP2 binds to methylated DNA and 
represses transcription (Geoffrey MC, 2000).
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1.2.2 Post-transcriptional gene regulation
RNA processing involves addition of 5 'cap, addition of 3 'polyA tail and removal 
of introns and represents another level of gene regulation. The sequence AUUUA in 
3'UTR is the signal for early degradation and short lifetime of mRNA. The higher the 
frequency of occurrence of this sequence, the shorter the life span of mRNA. Since the 
lifespan is encoded in nucleotide sequence, it is different for each mRNA and can not be 
varied. Information about the life span and stability of RNA is found in 3 'UTR 
(untranslated region) of gene. 3'UTR have been reported to affect gene expression by 
modulating RNA stability and translation (Casey et al., 1988 and Hentze et al., 1988). 
Role of 3 'UTR in suppression of basal and growth-hormone induced transcription has 
also been reported (Le Cam and Legraverend, 1995). UTRs of other genes have been 
reported to function as regulatory elements of the genes and affect transcription 
efficiency. Expression of human aggrecan gene has been reported to depend on the 
sequence present in 5'UTR (Wilmot et al., 1998) which is thought to serve as the binding 
site for general transcription factors that are needed for the assembly of transcription 
initiation complex. On the contrary, erythropoietin gene expression was reported to be 
enhanced upon removal of 5' and 3' UTRs (Park et al., 2001).
1.2.3 Translational gene regulation
Factors affecting mRNA translation includes m7G cap, length of 5 'UTR, position 
and context of initiator codon (AUG), and high order structure within mRNA (Nicola and 
Matthias, 1994). Structural elements in mRNA control translation initiation. Stability and 
position of secondary structure introduced into the 5 'UTR of mRNA has been reported to
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inhibit its translation (Lawson et al., 1986). When a secondary structure 12 nucleotide 
away from the m7G cap was introduced into mRNA, it strongly diminishes translation in 
vitro. Same structure, when placed 52 nucleotide downstream of the m7G cap, had no 
effect on translation. It is suggested that when the distance between the m7G cap and 
secondary structure was sufficient enough to allow 43 S entry, progression of 43 S pre­
initiation complex and associated factors occurred which disrupted the secondary 
structure and resulted in translation (Lawson et al., 1986). Various cellular mRNAs that 
code for transcription factors or growth factors have unusually long 5UTRs with 
upstream AUG, small ORF and strong secondary structures that result in poor translation 
(Kozak, 1991). For example mRNA of human platelet-derived growth factor-2 (PDGF2) 
has 5'UTR of 1022 nucleotides with 140 nucleotide GC-rich regions. GC-rich region 
immediately preceding AUG was found to be responsible for the poor translation of 
PDGF2. Role of secondary structure in 3UTR in regulation mRNA translation has not 
been established. However, long range interaction between 5 'UTR and 3 'UTR has been 
reported to regulate mRNA translation in Zea mays (Spena and Dobberstein, 1985).
Secondary structure in various mRNAs serve as binding sites for repressor protein 
and provides translational suppression and rapid regulation of gene/mRNA in response to 
cellular or extracellular stimuli. For example expression of ferritin (an iron storage 
protein) is regulated at translational level. Regions in the 5'UTR termed as iron 
responsive element (IRE) were capable of forming stem-loop structure and sufficient to 
control translation of ferritin mRNA in response to cellular iron concentration. (Hentze et 
al., 1987; Hentze et al., 1988). IRE is a highly conserved stem-loop structure which is 
important in mediating translational control in vivo and in vitro (Gray et al., 1993). A
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similar translational regulation has been identified in haem synthesis enzyme, erythroid 
5-aminolevulinic acid synthase (eALAS). An IRE was found in 5'UTR of eALAS 
mRNA to regulate the translation (Melefors et al., 1993). Multiple IRE have been 
reported in 3UTR of mRNA encoding transferrin receptor (involved in iron uptake in 
cell). However, translation is controlled here via change in mRNA stability (Klausner et 
al., 1993). Human thymidylate synthase (TS) mRNA has been shown to undergo 
translational autoregulation in vitro (Chu et al., 1993). A 29 nucleotide stem-loop motif 
in 5UTR of the mRNA, specifically interact with TS protein. Similarly human 
dihydrofolate reductase mRNA translation is also autoregulated. Role of RNA elements 
in such translational regulation is to provide access sites for repressor protein. Ribosomal 
protein synthesis is translationally regulated in Saccaromyces cerevisiae, Xenopus laevis, 
and mammalian cells. These mRNAs contain short 5'UTR (35-50 nucleotides), have a 
polypyrimidine tract (8-14 nucleotide) in cap-proximal position. 5 'UTR of Xenopus 
laevis S19 and murine S16/L30 mRNA are sufficient for regulation of translation. The 
polypyrimidine tract is necessary but has not been reported to be sufficient alone (Levy et 
a l, 1991).
Elements in 3UTR which serve as protein binding site can also regulate mRNA 
translation by mediating changes in poly-A tail length. Erythroide lipoxygenase LOX 
mRNA is expressed at early stage and must be translationally silenced in immature 
erythroide cells. 3'UTR (576 nucleotide) of rabbit (LOX) mRNA has ten repeats of 19 
nucleotide pyrimidine rich element and starts 50 nucleotide down stream from the 
translation termination codon (Fleming et al., 1989). Human reticulocyte LOX mRNA 
has four such repeats and sufficient for regulation. These pyrimidine repeats specifically
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interact with LOX-BP protein (48kDa) which represses LOX mRNA translation. UA-rich 
sequences in 3'UTR (associated with mRNA instability) also serve as binding site for 
repressor proteins and regulate translation of tumor necrosis factor mRNA translation 
(Goodwin et al., 1993).
Objectives
From the previous studies it has been established that mRNA of LDH 1 is present in both 
stages of asexual life cycle of T.gondii i.e. rapidly replicating tachyzoites and encysted 
bradyzoites. However, LDH1 protein is expressed only in tachyzoites but not in 
bradyzoites, suggesting a post-transcriptional and/or a translational suppression of LDH 1 
in bradyzoites. On the other hand LDH2 mRNA is present only in bradyzoites and is 
translated to LDH2 protein, showing a transcriptional regulation of the LDH2 gene (Yang 
and Parmley, 1997). Governing mechanism involved in distinct expression of two LDHs
i.e. LDH1 in tachyzoites and LDH2 in bradyzoites, is still unclear. Putative promoter and 
downstream sequence of LDHs have been reported to play a role in differential 
expression of LDHs during parasite stage conversion (Yang and Parmley 1997; 
Boothroyd et al., 1997). The study was divided into two parts, using plasmid 
pTub8mycHisGFP-HX as control in both parts of the study.
1. To refine the search for the putative promoter and downstream sequence for LDH1 and 
create a tool for the long term goal, using GFP reporter system, followings were the 
objectives.
a) To construct three different plasmids from the control and to generate four 
transgenic parasite strains from these plasmids. In transgenic control strain GFP reporter
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expression is under TUB8 promoter with a 3UTR of SAG1 downstream GFP. Among the 
three test transgenic strains, one strain has upstream sequence of LDH1 alone, other strain 
has both upstream and downstream sequence of LDH1, and the last strain has 
downstream region of LDH1 alone, such that the first two strains are under the control of 
putative LDH  promoter and the last strain is under TUB8 promoter control.
b) To determine GFP levels and its localization in both stages of T.gondii to 
establish the role of upstream and downstream sequence of LDH1 in translational 
suppression.
2. To create tools for the long term goal for the understanding of the mechanism behind 
transcriptional regulation of LDH2,
a) To generate two transgenic parasite lines using mycLDH1 and mycLDH2 as 
reporter, from the same control plasmid i.e. reporter expression is under the influence of 
Tub8 promoter and has 3'UTR of SAG1 downstream of the reporter.
b) To determine the levels of constitutive mycLDHl/LDH2 expression by western
blot.
c) To monitor the effect of LDH  misregulation on the phenotype of the both 
stages of the parasite.
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CHAPTER 2 
MATERIALS AND METHODS
2.1 Parasite strain and chemical supplies.
PLKAHX strain, used in this study was obtained from the AIDS Research and 
Reference Reagent Program, NIH. The T.gondii strain PLKAHX was derived from the 
slowly multiplying strain PLK. The gene encoding hypoxanthine-xanthine-guanine 
phosphoribosyltransferase has been silenced in the PLKAHX strain. This silencing allows 
the selection of the transgenic parasites (Donald and Roos, 1995; Donald et al., 1996).
Following is the list of chemicals and reagents used in this study along with the 
name of the supplier:
Amersham-Pharmacia Biotech (Baie d’Urfe, Quebec)
2' -deoxyribonucleoside 5'-triphosphate (dNTPs), nitrocellulose membranes.
Baxter Diagnostics Corp. (Toronto, ON)
Nalgene™ disposable 25mm syringe filters (0.2 pm pore size) and glass Pasteur pipettes. 
Bio-Rad Laboratories (Mississauga, ON)
Bromophenol Blue, Coomassie brilliant blue R-250, Xyelene Cyanol, protein molecular 
weight standards (medium range), and protein assay dye reagents.
Carolina Biological Inc 
Restriction enzyme BamHI 
Gelman Sciences (Ann Arbor, MI)
The Vacucap™ disposable bottle-top filter for sterilization of media.
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GibcoBRL Invitrogen (Burlington, ON)
Cell culture media Dulbeco’s modified essential medium (DMEM), minimal essential 
medium (MEM), Dulbeco’s phosphate buffered saline (DPBS) supplemented with 
calcium, trypsin, penicillin-streptomycin (10 pg/ml), L-glutamine.
Hyclone (Logan, UT)
1 0 % cosmic calf serum.
Invitrogen Corporation (Burlington, ON)
Proteinase K, Trizol reagent, and RNase out ribonuclease inhibitor.
NewEngland Biolabs Inc 
Restriction enzymes Kpnl, Nsil, Pstl.
Promega (Madison, WI)
Agarose, Mung Bean Nuclease, T4 DNA ligase, Moloney murine leukemia virus reverse 
transcriptase (M-MLV), RQ1 RNase free DNase, DNA ladder lkb and 100 bp, Multicore 
buffer, EcoRI, Hindlll.
Qiagen (Mississauga, ON)
QIAEX® I and plasmid midi prep kits for DNA purification.
Roche Diagnostics (Laval, Quebec)
Taq DNA polymerase.
Sigma-Aldrich (Oakville, ON)
Acetic acid, ampicillin, tetracycline, chloroform, 4 ',6  diamidino-2-phenylindole (DAPI), 
Dolichos biflorus conjugated to fluorescein isothiocyanate, dimethylsulfoxide (DMSO), 
dithiothreitol (DTT), diethylpolycarbonate (DEPC), ethanol, agar, ethidium bromide, 
formaldehyde, glycine, glycerol, hydrochloric acid, mycophenolic acid (MPA),
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polyoxyethylene sorbitan monolaurate (Tween-20), 2-propanol, phenyl methyl sulfonyl 
fluoride (PMSF), sodium citrate, sodium chloride, sodium acetate, tris­
hy dr omethyl aminomethane (Tris), Triton X-100, Trichloroacetic acid, Xanthine, midi- 
prep plasmid purification kit.
Stratagene (La Jolla, CA)
XL1BL bacterial strain.
TaKara Bio Inc 
Restriction enzyme HincII 
USB (Cleveland, OH)
Acrylamide, bis-acrylamide, ammonium persulfate (APS), equilibirated phenol, RNaseA, 
Sodium dodecyl sulphate (SDS)
Nucleopore (ON)
Polycarbonate filters (3 pm pore size)
Wisent (Montreal)
Dialyzed fetal bovine serum (FBS)
pTUB8 mycHisGFP-HX plasmid (kindly donated by Dr. Dominique Soldati)
2.2 Apparatus and Instrumentation
Miniature Horizontal Gel System MLB-06 from Tyler Research Instruments was 
used for DNA agarose gel electrophoresis. Gels were viewed and images were captured 
using Alphalmager™ 2200 Light Imaging system with AlphaEase software. Vertical gel 
electrophoresis system, including all glasses, Teflon combs and spacers from BRL
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(Bethesda Research Laboratories) were used to run Sodium dodecyl sulphate-poly 
acrylamide gel electrophoresis (SDS-PAGE).
J2-HS centrifuge (Beckman), desktop Eppendorf Model 5415C microcentrifuge 
from Desaga (Sarstedt Gruppe, Germany) or BR4i Centrifuge (Jouan, SA) were used to 
carry out centrifugations.
Protein quantification was performed using Shimadzu UV-Visible Recording 
spectrophotometer, Hadley Tekscience.
Polymerase chain reaction (PCR) was carried out using 20-well Techgene 
Thermal Cycler (Techgene. Cambridge, UK). Ligation reactions were performed in 48- 
well Perkin Elmer Cetus DNA thermal Cycler (Perkin Elmer. Norwalk, CT).
Cell and parasite cultures were conducted in the class II type A/B3 Biosafety 
cabinet (Jouan, SA). All cultures were maintained in a CO2 incubator (Thermoforma). 
Electroporations were performed using BTX model; 600 Electro Cell Manipulator 
(Genetronics). All Bacterial cultures were grown in NEW BRUNSWICK SCIENTIFIS 
G-25R shaking incubator.
All glassware, broth solutions were autoclaved prior to use in order to maintain 
sterile conditions throughout bacterial culturing.
2.3 General methods
2.3.1 Agarose gel electrophoresis
Miniature Horizontal Gel System MLB-06 (Tyler Research Instruments, 
Edmonton) was used for agarose gel electrophoresis. 1% (w/v) Agarose gel was made by 
dissolving solid agarose in Tris-acetate EDTA (TAE) buffer, 40 mM Tris-acetate, ImM
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EDTA. Ethidium bromide was later added to a final concentration of lOng/ml. The gel 
was first allowed to solidify in the electrophoresis tray and than immersed into the 
electrophoresis tank filled with lx TAE buffer. DNA samples were mixed with the gel 
loading buffer (0.025% Bromophenol blue, 0.025% Xyelene Cyanol FF, lOmM EDTA 
pH 8.0 and 98% deionized formamide) and were loaded into the wells. DNA marker was 
loaded and the gel was electrophoresed for 30-45 min at 100V (Sambrook 1989). The 
gels were visualized using Benchtop Ultraviolet Transillumoinator (YWR Scientific. 
Mississauga, ON). Alphalmager 2200 Light Imaging System with AlphaEase Software 
was used to capture gel images and for the photography of ethidium bromide stained 
agarose gels (Alpha Innotech Corporation, San Leandro).
2.3.2 Reverse Transcription (RT)
Reverse transcription reaction was carried out by mixing 2pg of extracted RNA 
with 50 pico moles of oligo dT. This was incubated at 70°C for 5 minutes to remove 
RNA secondary structure and then chilled on ice for 1 minute. The mixture was 
completed to 10 pi by adding in order, 2pl of M-MLV reverse transcriptase 5 x buffer, 
1.5pl of dNTPs (2.5 mM), 0.5pl of RNaseOut (40 U/pl), lp l of M-MLV reverse 
transcriptase (50U/pl) and incubated for 1 hr at 37°C. Reverse transcriptase was then heat 
inactivated at 95°C for 5 minutes. 4pl of the RT-mixture was used as a template for 
subsequent PCR amplification. Any genomic DNA contamination was checked by 
running a PCR using ROP1 primer. No PCR amplification indicated that RNA sample is 
un-contamination.
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2.3.3 Polymerase Chain Reaction (PCR)
Polymerase chain reaction (PCR) was performed using 20-well Techgene thermal 
cycler (Techne, Cambridge, UK). The PCR was performed in a total volume of 50pl 
containing 75mM Tris-HCl pH 8 .8 , 50 mM KC1, 2mM MgCl2, 50 mM dNTPs, 2 U of 
Taq DNA polymerase and 0.5 pi of oliginucleotide primers (100 pmol/pl). The 
amplification reaction included 35 cycles each consisting of denaturation at 94°C for 30 
sec, annealing at 55°C for 30 sec, and extension at 72°C for 45sec. lp l of genomic DNA, 
as a positive control and autoclaved water, as a negative control were used as templates in 
the amplification reaction. Amplified product was resolved in a 1% (w/v) agarose gel.
2.3.4 Host cell culture
Human foreskin fibroblasts (HFF; obtained from Dr.Roos, University of 
Pennsylvania) were used as a host for the intracellular parasite T.gondii. These HFF cells 
were grown as a monolayer in Dulbecco’s Modified Eagle Medium (DMEM) 
supplemented with 5ug/ml streptomycin, 5units/ml penicillin and 10% cosmic calf serum, 
in a 5% C 0 2 atmosphere.
To propagate the host cells, confluent HFF cultures were detached by adding 1 ml 
of Trypsin EDTA solution (0.25% trypsin, 0.3%EDTA) followed by incubation at 37°C 
for 45 seconds. Detached cells were suspended in fresh media and split into 3-4x the area 
of old culture.
To freeze the host cells for later use, cells were pelleted after trypsin treatment. 
These pellets were resuspended in cell freezing medium containing 25% dimethyl
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sulfoxide (DMSO) and 20% dFBS (dialysed fetal bovine serum) in DMEM and were 
immediately placed in cryovials and were stored at -80°C.
2.3.5 Toxoplasma gondii Culture
Toxoplasma gondii was propagated in HFF grown in MEM medium with L- 
glutamine, supplemented with 1% dialyzed fetal bovine serum. Parasites scraped from 
infected HFF monolayers were used to infect a new monolayer of HFF grown in MEM 
medium (Donald and Roos, 1994).
2.3.6 Parasite Pelleting
Freshly released tachyzoites from HFF monolayer were scraped, passed through a 
27 G-l/2 syringe needle to release parasites from vacuole, filtered through a 3pm 
polycarbonate filter to remove all the host cell debris, and than pelleted by centrifugation 
at 2000-3000 rpm for ten minutes. Parasite pellet were stored at -80°C for later use for 
genomic DNA, RNA or protein isolation.
2.3.7 Genomic DNA Isolation
Genomic DNA was extracted by resuspending the parasite pellet in 0.2 ml lysis 
buffer (ImM EDTA, lOmM Tris pH 8.0, 0.5% SDS, 0.2pg/pl Proteinase K, 0.125pg/pl 
RNase) followed by incubation at 56° C for 4-6 hrs. The suspension was extracted twice 
with 0.2 ml of phenol: chloroform: isoamyl alcohol and once with chloroform. Genomic 
DNA was then recovered from the aqueous phase and precipitated with 0.1 volume 3M 
sodium acetate and 2.2 volume 95% ethanol followed by centrifugation at 7500 rpm for
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10 min. Genomic DNA pellet was washed using 70% ethanol and dried followed by 
resuspension in 2 0 pl autoclave water.
2.3.8 RNA extraction from T.gondii
Parasite pellet was lysed with 500pl Triziol reagent and incubated for 5 min at 
room temperature to permit a complete dissociation of nucleoprotein complexes. lOOpl of 
chloroform was added to the mixture and was shaken vigorously for 15 seconds and 
incubated at room temperature for 2 min. Phase separation was carried out by 
centrifugation at 12000 rmp at 4°C for 15 minutes. The upper aqueous layer containing 
RNA was precipitated by 250pl of isopropyl alcohol and incubated at room temperature 
for 10 minutes and then centrifuged at 10000 rpm for 10 minutes at 4°C. Precipitated 
RNA was washed with 500pl of 70% ethanol and resuspended in DEPC-treated water. 
Any genomic DNA contamination was removed by treating the RNA with 4 units of RQ1 
RNase-free DNase for 20 minutes at 37°C. DNase was subsequently inactivated by 
heating at 75°C for 5 minutes.
2.3.9 Protein quantification by Bradford Assay
Bradford assay was used to determine protein concentration using the Agilent 
UV-visible spectrophotometer (Shimadzu). Parasite pellets were completely resuspended 
in 200 pi of lysis buffer (HEPES 50pM, PMSF 5pM, Triton X I00 0.025%, Glycerol 
20%) and centrifuged at 13000 rpm for 10 min and the supernatant having protein in it, 
was collected in a separate tube. The protein sample was mixed with 0.7 ml of working 
Bradford reagent and incubated for 10 min at room temperature. Using the Bradford
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reagent as blank, spectrophotometric measurements were carried out at 595 n.m. A 
standard curve made from standard protein solution of BSA was used to determine the 
concentration of the unknown protein in the test samples (Sambrook 1989).
2.3.10 Sodium dodecyl sulphate-Polyacrylamide gel electrophoresis
A discontinuous buffer system was used to conduct sodium dodecyl sulphate- 
polyacrylamide gel electrophoresis (SDS-PAGE) (Laemmli, 1970). The stacking and 
resolving gels were caste in a vertical gel electrophoresis system from BRL (Bethesda 
Research Laboratories). The resolving solution was poured first and left to polymerize, 
then stacking gel was overlaid on to it. Samples were mixed with the gel loading buffer 
(Appendix) and boiled for 5 min, centrifuged at 13000 rpm for 30 sec and then loaded 
into the wells. The gel was run with Tris-Glycine running buffer (25mM Tris, 192 mM 
Glycine and 1%SDS) at 130 volts until the bromophenol dye came out of the gel.
2.3.11 Electro-blotting and immunodetection
The proteins were transferred to nitrocellulose membrane at 130 mA for 2 hrs, in 
the transfer buffer (20mM Tris pH8.0, 150mM Glycine and 20% methanol) using electro- 
blotting (BIO-RAD) apparatus. The blot was incubated with the blocking buffer (5% 
non-fat dry milk in TBS) for 1 hr at room temperature on a shaker, followed by one wash 
with TBS buffer. The blot was then incubated with the primary antibody solution 
(GFP/LDHl/His antiserum, diluted to 1:500 in 2.5% non-fat dry milk in TBS) for over 
night on a shaker at 4°C. Blot was washed 3x5 minutes with TBST (TBS containing 0.1% 
Tween20) and incubated with anti-rabbit/goat IgG-HRP conjugate (diluted 1:10,000 in
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2.5% non-fat dry milk in TBS) for 1 hr at room temperature on a shaker. Finally, the blot 
was washed twice with TBST and the product was revealed using ChemiGlow West 
detection kit (Alpha Innotech).
2.3.12 Immunofluorescence assay
Host cells, HFF, were grown as monolayer in a culture plate with glass cover 
slips. Using the selection medium, these monolayers were infected with the following 
parasite strains i.e. negative control (PLKAHX), transgenic control (mycHisGFP-HX) 
and the three test strains (5'UTRGFP-HX, 3 '5 'UTRGFP-HX, 3'UTRGFP-HX), and 
allowed to grow for 4-5 days. After aspirating off the culture media, the cells were 
washed thrice with Dulbeco’s phosphate buffered saline (DPBS) and were fixed with 3% 
paraformaldehyde in phosphate buffered saline (PBS) for 10 minutes. Cells were 
permeabilized with 0.25% Triton X-100 in PBS for 10 minutes. After washing twice with 
PBS, the cells were blocked with 5% Bovine serum albumin (BSA) in PBS for an hour at 
room temperature (Yahiaoui et al., 1999). Cover slips were then incubated with the 
primary antibody (Goat GFP anti-serum diluted 1:200 Rockland Inc Gilbertsville, PA) in 
a humidity chamber for 2 hrs at room temperature. After three washes with PBS, cells 
were incubated with rabbit anti-goat IgG conjugated to rhodamine (diluted 1:300, 
Rockland Inc Gilbertsville, PA) in a dark humidity chamber for 1 hour and washed with 
the PBS again. For cyst staining, cells were incubated with Dolichos biflorus agglutinin 
conjugated to FITC (diluted 1:300, Sigma) for 1 hour. Cellular nuclei were stained by 
incubating the cells for 10 minutes with 4 ', 6  diamidino-2-phenylindole (DAPI, Sigma), 
followed by three washes with PBS. Cover slips were placed carefully on the glass slides
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and were allowed to dry and finally overlaid with fluoromount and examined with a 
Leica DMIRB microscope. All images were taken with a cooled Q-Imaging CCD camera 
using Improvision Openlab software.
2.4 Plasmid construction and purification
For genetic studies in T. gondii, electroporation is the most efficient means of 
transformation. Parent plasmid pTUB8mycHis GFPHX (6418-bp) has GFP as a reporter 
gene. The sequence and map of this plasmid can be found in Appendix A. It has 3 'UTR 
(untranslated region) of SAG1 (surface antigen) downstream GFP. Under the control of 
tubulin promoter it can produce GFP fused to Myc and 6 xHis tags at the N-terminus. This 
plasmid carries an ampicillin resistant gene for bacterial selection and an expression 
cassette of hypoxanthine-xanthine-guanine phosphoribosyltransferase (HX) that allows 
the selection of stably transformed parasites when media is supplemented with the drug 
mycophenolic acid and xanthine as a substrate. Parent plasmid pTUB8 mycHisGFP-HX 
was used to generate two sets of plasmids.
2.4.1 Construction of plasmid with GFP reporter gene
To investigate the role of 5'UTR and 3'UTR of LDH 1 (lactate dehydrogenase) or 
either one of them, in translational suppression of LDH 1 enzyme during bradyzoite stage, 
the parent plasmid was modified to produce three different plasmids as follows,
1. For the investigation of the role of 5 'UTR of LDH 1 alone, Tub 8 promoter was 
replaced by upstream sequence of LDH1 (626-bp) and the plasmid was named 
p5'UTRL1GFP-HX. This plasmid still has 3'UTR of SAG1 downstream GFP. The
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sequence and map of this plasmid can be found in Appendix A. The parent plasmid was 
digested by Kpnl and EcoRI to remove the Tub8 promoter (495-bp) from the parent 
plasmid and then gel purified. EcoRI site was made blunt by treating with mung bean 
nuclease. In order to remove 5 TO 4 group from the linearized plasmid, it was treated with 
alkaline phosphatase to help in later ligation reaction. Again using genomic DNA as a 
template, the upstream region of LDH 1 (626-bp) was amplified, and extracted from the 
gel as mentioned above. Kpnl and Hindlll restriction sites were introduced using specific 
nucleotide primers named as Hindlll dws 600 LDH1 and Kpnl ups 600 LDH1 
respectively. The sequences of the primers are listed in Appendix A. Phosphorylation of 
the insert was done to help in ligation. Hindlll site was made blunt by mung bean 
treatment. Phenol chloroform extraction and ethanol precipitation was done. This insert 
was ligated into the resulting plasmid p5UTRLlGFP-HX. Parasite strain generated from 
this plasmid was 5UTRGFP-HX
2. For the investigation of the role of 3'UTR of LDH 1 alone, 3'UTR of SAG1 
was replaced by downstream sequence of LDH1 and the plasmid was named 
p3'UTRLlGFP-HX. This plasmid is still under the influence of Tub8 promoter. The 
sequence and map of this plasmid can be found in Appendix A. The insert, downstream 
sequence of LDH1 (794-bp), was made by PCR from genomic DNA. PacI and BamHI 
restriction sites were introduced by specific nucleotide primers named BamHI 3UTR dws 
78LDH1 and PacI 3UTR ups 780 LDH1. The sequences of the primers are listed in 
Appendix A. Restriction sites were introduced for later sticky end ligation reaction. PCR 
product was run on gel and 794-bp band was excised from the gel and purified using 
QIAEX®II Gel Extraction kit from QIAGEN. Parent plasmid was digested with BamHI
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and PacI enzymes. 3 'UTR of SAG1 (320-bp) was removed from the parent plasmid. The 
digested plasmid was run on gel, and 6098-bp band was excised and gel purified as 
described above. Using purified plasmid, 794-bp insert was ligated in. This plasmid was 
named p3UTRLlGFP-HX. Parasite strain generated from this plasmid was 3UTRGFP- 
HX.
3. For the investigation of the role of both 3 'and 5'UTR of LDH1, 3'UTR of 
SAG1 from plasmid 5'UTRGFP-HX was replaced by the downstream sequence of LDH 1 
and named p3'5'UTRLlGFP-HX. Using p3'UTRLlGFP-HX plasmid, Tub8 promoter 
(495-bp) was digested and removed using Kpnl and EcoRI enzymes. EcoRI site was 
made blunt and the insert was ligated as described above. Parasite strain generated from 
this plasmid was 35UTRGFP-HX. The sequence and the map of this plasmid can be 
found in Appendix A.
Parent plasmid pTUB8mycHisGFP-HX served as a positive control. Gene bank accession 
numbers for LDH1 and LDH2 mRNA are U35118 and U23207 respectively.
2.4.2 Construction of plasmid with mycLDHl/LDH2 reporter gene
Using the same parent plasmid i.e. pTUB8 mycHisGFP-HX, another set of 
plasmid was generated to investigate that if the above hypothesis is true (3 'and 5 'UTR of 
LDH1 do play a role in translational suppression) then a) can the removal of suppression 
(3'and 5'UTR of LDH 1) in bradyzoites result in continuous LDH1 expression and b) can 
the overexpression of LDH2 in tachyzoites force encystation. Two following plasmids 
were generated from the same parent plasmid.
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1. Genomic DNA from T.gondii was used as a template for reverse transcription 
reaction to get complementary DNA (cDNA) and then PCR was done to amplify open 
reading frame (ORF) of LDH1 (990-bp). Specific primers were used to introduce Nsil 
and PacI sites and named as 3LDH PacI and 5LDHx Nsil respectively. Specific 
sequences of the primers are listed in Appendix A. The parent plasmid, 
pTUB8mycHisGFP-HX was digested with Nsil and PacI enzymes and GFP was 
removed. ORF of LDH 1 was ligated in the plasmid by sticky end ligation. In this plasmid 
GFP reporter was replaced with open reading frame of LDH 1 enzyme and the plasmid 
was named pmycLDHl-HX. The parasite strain generated from this plasmid was 
mycLDHl-HX.
2. The second plasmid was made in a similar fashion as the one described above. 
In this plasmid, however, ORF of LDH2 (982-bp) was ligated in the plasmid at Nsil and 
PacI sites. GFP reporter was replaced with open reading frame of LDH2 enzyme and the 
plasmid was named pmycLDH2-HX. The sequence and the map of this plasmid are listed 
in Appendix A. The parasite strain generated from this plasmid was mycLDH2-HX.
Both of these plasmids are under the control of Tub8 promoter, have ten amino acid myc- 
tag, 8 x His tag, ampicillin resistance, and HX as selectable marker. The parent plasmid 
pTUB8mycHisGFP-HX served as a positive control again in this set of experiment.
2.5 Plasmid transformation into E.coli
2.5.1 Preparation of competent bacteria
XLiBL E.Coli cells were grown on agar plate containing tetracycline (0.1g/l). A 
single colony was picked from the plate & inoculated into 5mls of LB with tetracycline
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and incubated overnight in the shaker incubator at 37 °C. Next day it was transferred to 
500 ml LB and incubated for 3 hrs of vigorous shaking. The bacteria were then chilled in 
ice for 15 min and then pelleted at 5000 rpm for 15 min at 4°C. Pellet was resusupended 
in 100 ml of Cold sterile CaC^ (lOOmM) and then centrifuged again at 5000 rpm for 15 
min at 4°C. The pellet was washed three times with 50ml of CaCL solution and 
centrifuged as described. Finally the pellet was resuspended in 200mM CaCL and 25% 
glycerol and then aliquoted into microfuge tubes and stored at -80°C for later use 
(Sambrook, 1989).
2.5.2 Transformation of competent bacteria
5pl of the ligation reaction product was mixed with 25 pi of freshly thawed 
competent E. Coli cells and incubated on ice for 20 min. The cell suspension was heat- 
shocked for 45 sec at 42°C and incubated on ice for another 2min. 400pl of LB broth was 
added to the cells and incubated for 30 min at 37°C with shaking. Cells were centrifuged 
at 1000 rpm for 30-45 sec. 300pl of supernatant was discarded and the remaining lOOpl 
was used to spread on LB agar plate containing 0.1 g/1 ampicillin. Plates were then 
incubated for overnight at 37°C (Sambrook, 1989).
2.5.3 Plasmid isolation from transformed bacteria
After the positive clones were identified, recombinant plasmids from transformed 
bacteria were isolated by plasmid mini-preparations (Sambrook, 1989). Confirmation of 
ligation was done by restriction mapping. Large scale plasmid preparation was performed
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using Gen Elute™ HP Plasmid Midiprep kit from sigma for later electroporation of 
plasmid into the parasites.
2.6 Generation of stable transgenic parasite lines
Two sets of transgenic parasite lines were generated using the above mentioned 
plasmids. In the first set, parent and three modified plasmids were electroporated into 
PLKAHX strain. As a result, four transgenic parasite lines were generated to investigate 
the transcriptional regulation of LDH1 in tachyzoites and bradyzoites. In the second set, 
the parent plasmid and the two modified plasmids were electroporated into PLKAHX 
strain. As a result, three transgenic parasite lines were generated to investigate the 
translational suppression of LDH2 in tachyzoites.
Freshly lysed out Toxoplasma gondii tachyzyotes from confluent HFF monolayer 
were scraped from culture plates, syringed through a 21-G needle to release the parasite 
from host parasitophorous vacuole, filtered through a 3 pm membrane to remove host 
cell debris and then sedimented by centrifugation at 2000-3000 rpm for 10 min at room 
temperature. The collected parasite pellet was washed with Dulbecco’s phosphate
4-9 •buffered saline supplemented with 0.1 g/1 Ca (DPBS) prior to electroporation. The 
washed pellet was resuspended in 400 pi cytomix buffer (120mM KC1, 0.1 mM CaCL, 
lOmM K2HPO4, KH2 PO4, pH 7.6, 2 mM EDTA, 5Mm MgCh) freshly supplemented 
with 5mM glutathione and 2 mM ATP. Electroporation makes the cells sensitive to the 
osmolarity and ionic composition of the medium. Use of potassium phosphate-based 
cytomix buffer resembles the ionic composition of the cytosol and help increasing the 
cell survival to a greater extent. lOpg of the purified Plasmid/transforming DNA was
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added to the parasite suspension in a 4mm sized electroporation cuvette. Using BTX 
model 600 Electro Cell Manipulator (Genetronics) (250, current, 1.8 kEV, 25uF), this 
mixture was subjected to electroporation and then incubated for 30 min at room 
temperature. The electroporated parasites were then inoculated to a fresh confluent HFF 
cells (Donald and Roos 1994). Stable populations were selected using 25 jig/ml 
mycophenolic acid as an inhibitor to inosine monophosphate dehydrogenase (IMPDH) 
and 50pg/ml xanthine as a substrate. Both of these were added to the culture media 
(Donald and Roos 1998).
2.6.1 Differentiation of the parasites
HFF monolayers were infected with 4 xlO4 of the transgenic parasites and allowed 
to grow in EDI medium. After four hours, all the remaining extra cellular parasites were 
removed by aspirating off the EDI. Culture medium was replaced with RPMI 1640 
medium, having 5% fetal bovine serum (FBS), 50mM HEPES, 20mg of antimycotic/L 
and with pH 8.2. Parasites were allowed to grow in low CO2 environment (0.4%) for five 
days. RPMI medium lacks growth factors and has a high pH. This, along with low CO2 
induces switching of tachyzoites into bradyzoites.
2.7 Confirmation of transgene integration by PCR
Confirmation of clones with GFP reporter plasmids, and mycLDHl/LDH2 
plasmids was done using PCR as described in general methods. PCR products were 
visualized in 1.5% agarose gel.
40
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
2.7.1 Confirmation of the UTR clones
Different set of primers were designed for the confirmation of the clone. Primer 
set A has primers named 5PL1 and 3GFP1491 and was designed to amplify a 500-bp 
long DNA sequence, encompassing an area from upstream region of LDH1 to GFP for 
the confirmation of 5 'UTRGFP-HX and 3'5'UTRGFP-HX clones. The parent plasmid 
p5'UTRGFP-HX was used as a positive control. Primer set B consists of primers named 
5 GFP 1667 and 3UTRL1 and was designed to amplify a 600-bp long DNA sequence that 
covers the area from GFP to downstream region of LDH1 and was used for the 
confirmation of 3 'UTRGFP-HX and 3'5'UTRGFP-HX clones. Primer set C, consisting 
of primers 5GFPmyc and 3GFP1940 was designed to amplify 700-bp band from GFP 
reporter. Parent plasmid p3'UTRGFP-HX was used as positive control. Wild type 
parasite strain i.e. PLKAHX served as a negative control for all of these primer sets.
2.7.2 Confirmation of the mycLDHl/LDH2 clones
In order to confirm the transgenic LDH1 and to differentiate it from the native 
LDH1 different pairs of primers were designed. Primer set D, that has primers LDH-ORF 
sense and LDH-ORF antisense was designed to amplify a 300-bp band from the open 
reading frame (ORF) of the LDH1 that was ligated in place of GFP. The genomic LDH1 
of toxoplasma however, has an intron of approximately 537-bp size within its ORF. 
Primers could amplify a 300-bp band from transgenic LDH1 or 837-bp band using 
genomic LDH1 as their template. Similarly mycLDH2 clone confirmation was carried out 
using primer set E, having primers LDH2 forward and LDH2 reverse that amplifies a 
480-bp band from the open reading frame of LDH2 that was ligated in the parent plasmid
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in place of GFP. Again the genomic LDH2 of toxoplasma has an intron of 587-bp size 
with in its ORF. The primers could amplify 480-bp band when transgenic LDH2 was 
used as a template and a 1067-bp band when genomic LDH2 was used as template. 
Sequences of these primers are listed in Appendix A.
2.7.3 mycLDHl/LDH2 clone confirmation by restriction digestion
In order to further confirm the transgenic LDH expression, restriction enzymes 
specific to LDH1 and LDH2 were used. PCR product (1 OOjllI) of transgenic LDH1 and 
LDH2 were first phenol: chloroform extracted and then ethanol precipitated. Respective 
DNA pellets were resuspended in 10 pi autoclave water and used for restriction 
digestion. Restriction digestion was performed in a 15pi total volume having 2pl DNA,
1.5 pi of lOx enzyme buffer, 0.5 pi enzyme and 11 pi of sterile water. This mixture was 
incubated at 37°C for overnight and then visualized in 1.5% agarose gel. For the 
confirmation of mycLDHl clone, HincII enzyme that cuts the ORF of LDH1 was used, 
while PstI enzyme that cuts the ORF of LDH2 was used for the confirmation of 
mycLDH2 clone.
2.8 Expression of reporter gene in T.gondii
Expression of GFP and mycLDHl/LDH2 were measured using western blot as 
described in general methods.
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2.8.1 Expression of GFP
In order to examine the expression of GFP gene products, a western blot analysis 
was performed using polyclonal antibodies, in wild type and transgenic parasite lines. 
Equal amounts of protein extracts from PLHAHX, mycHisGFP-HX, 35UTRGFP-HX, 
3UTRGFP-HX, and 5UTRGFP-HX were immunoblotted and incubated with affinity 
purified antibody specific to GFP raised in goat (1:500) Rockland Inc. Antigoat IgG-HRP 
conjugate was used in 1:1000 dilution. Proteins from host HFF cells were also loaded in 
equal amounts to eliminate the possibility of cross contamination. In order to compare 
GFP expression with native LDH1 expression, the same blot was stripped with 0.1 M 
Glycine. HC1 buffer (pH 2.5-3), washed twice with TBST and a western blot was 
performed using rabbit antiLDHlserum (1:500) from Sigma. Anti-rabbit IgG-HRP 
conjugate (Sigma) was used as the secondary antibody.
2.8.2 Expression of mycLDHl/LDH2
Equal amounts of protein extracts from PLKAHX, mycLDHl, mycLDH2 were 
immuno-blotted and incubated with affinity purified antibody specific to 6 xHis tag 
(1:500) raised in rabbit (Rockland Inc). Anti rabbit-IgG-HRP conjugate (1:10,000) was 
used as the secondary antibody. Protein extracts from human foreskin fibroblasts (HFF) 
were also subjected to western blotting to make sure there is no cross contamination. 
Equivalent amounts of the same protein preparations were subjected to western blot 
analysis using antibody against LDH1 to ensure that comparable amounts of cell free 
lysates were loaded and probed.
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2.9 Localization of GFP
Subcellular localization and abundance of GFP was monitored by measuring 
immunofluorescence. Transgenic parasite lines as well as the wild type PLKAHX were 
subjected to immunofluorescence assay using GFP-specific polyclonal antisera raised in 
goats (1:200) from Rockland Inc. Anti goat IgG-rhodamine conjugated was used to 
reveal the location of GFP. Nuclear staining was done using DAPI (1:15) which was used 
as an internal control.
2.9.1 GFP localization in tachyzoites
In order to estimate the abundance of GFP among three test transgenic parasite 
lines as compared to the transgenic positive control and the wild type, DAPI was used as 
an internal control. Intensities of rhodamine fluorescence signals and that of DAPI were 
quantified. The relative fluorescence was determined by the ratio of GFP signals with 
reference to DAPI signals.
2.9.2 GFP localization in bradyzoites
HFF monolayers were grown in plates with cover slips; parasites were inoculated 
and were allowed to invade for four hours in EDI medium. After that EDI was replaced 
with RPMI medium that lacks growth factors and have high pH and parasites were 
allowed to grow in low CO2 environment for five days to induce switching to bradyzoites 
as described in general methods. Parasites reside within a cyst in bradyzoite stage. 
Fluorescein isothiocyanate (FITC)-conjugated Dolichos biflorus lectin (1:300) that 
specifically binds to the N-acetylglucosamine moiety within the cyst wall was used as a
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marker for cyst wall development (Tomavo, 2001). Localization and abundance of GFP 
was monitored, along with the presence of cyst wall, using GFP specific polyclonal 
antisera raised in goat. A rhodamine conjugated anti goat was used to reveal the signals 
of GFP as was done in tachyzoites. DAPI was used again as an internal control to stain 
the nuclei.
2.10 Growth assay
In order to assess the growth rate and infectivity of parasites, plaque assays were 
done. Freshly released parasites from wild type and all transgenic strains were stained 
with 0.4% Trypan blue and counted under microscope. Live parasites were able to pump 
out the blue dye and appeared transparent while dead parasite showed blue color. 
Confluent HFF monolayers in 35mm culture plates were inoculated with 4-5 x 104 
parasites from control and test strains. Parasites were allowed to grow undisturbed in 
EDI medium for 8-10 days and then media was aspirated off. The infected monolayer 
was rinsed with PBS, fixed with methanol (95%) for five minutes and then stained with 
lx crystal violet ( 5x stock: 25g crystal violet in 250 ml methanol, volume made up to 
1000ml with 1% ammonium oxalate). Monolayers were finally washed with PBS and 
air-dried. Parasite plaques appear as irregular clear areas against violet background of 
HFF monolayer.
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CHAPTER 3 
RESULTS
In order to investigate the mechanism behind differential expression of LDH1 and 
LDH2 during stage conversion the study was divided into two parts. The first part was 
designed to elucidate the influence of 5' upstream and 3 'downstream sequence of LDH1 
on the expression of LDH1 using GFP as a reporter system. The experiments in the first 
part were aimed at understanding translational suppression of LDH1. The second part 
was aimed at the investigation on how the expression of LDH2 in the tachyzoites and that 
of LDH1 in bradyzoites, will influence the life cycle of T.gondii.
3.1 Translational suppression of LDH1
Four transgenic parasite lines were generated, as described in Materials and 
Methods section 2.4.1, for the investigation of the translational suppression of LDH1 
during stage conversion. These parasite strains were referred to as mycHisGFP-HX, 
5'UTRGFP-HX, 3'5'UTRGFP-HX, and 3 'UTRGFP-HX. The strain mycHisGFP-HX 
was used as a positive control while the remaining three were tested strains. Their names 
reflect the genetic material carried by them. For example, the strain 5'UTRGFP-HX has a 
626-bp upstream region of LDH1 to control the expression of reporter GFP and 
HXGPRT as a selectable marker. All parasite lines were generated using PLKAHX. Thus 
PLKAHX served as a negative control for the study.
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3.1.1 Confirmation of transgene integration
To determine that the GFP reporter system was integrated into the genome of the 
transgenic parasites, PCR analysis was performed using genomic DNA as starting 
material. In order to amplify a specific segment of the reporter system, several pairs of 
PCR primers were designed as shown in Figure 3.1 A. Using primer set A (Material and 
Methods 2.7.1) a 500-bp band was amplified from 5 'UTRGFP-HX and 3'5'UTRGFP- 
HX as shown in left part of Figure 3.1 B. This band was not amplified when genomic 
DNA from PLKAHX, mycGFP-HX or 3'UTRGFP-HX was used as template. This 
further confirmed the specificity of the primers for the clones. Parent plasmid 
p3'5 'UTRGFP-HX was used as a positive control for PCR and gave a very bright 
prominent band as compared to the clonal parasite strains depending upon level of 
expression.
Similarly when the genomic DNA from all transgenic and wild type parasite 
strains were subjected to PCR amplification using primer set B (Materials and Methods 
2.7.1) that uses GFP-3'UTR of LDH1 as a template, a 600-bp band was amplified from 
3'5'UTRGFP-HXand 3 'UTRGFP-HX as shown in right part of Figure 3.1 B. Again this 
band did not appear when the genomic DNA from wild type, mycHisGFP-HX, and 
5 'UTRGFP-HX were used as template again indicating the specificity of the primers. 
Parent plasmid p3'5 'UTRGFP-HX was used as a positive control and produced a 
prominent band as compared to the parasite clones. Primer set C somehow did not 
produce any band when used with genomic DNA from transgenic strains, even though it 
amplified a 700-bp band from parent plasmid pTub8mycHisGFP-HX data not shown 
here.
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Figure 3.1 
Confirmation of transgene integration 
Legend
A. Schematic presentation of the primer design. Primer set A has 5' and 3' primers 
named 5PL1 and 3 GFP 1491 that were designed to amplify a 500-bp band from DNA 
segment encompassing an area from 5'UTRLDH1 to GFP. This set of primers was used 
for the confirmation of upstream region of the clones. Primer set B has 5' and 3' primers 
named 5GFP1667 and 3UTRL1 and were designed to amplify a 600-bp band using DNA 
segment from GFP to 3'UTRLDH1 as their template. This set of primer was used for the 
confirmation of down stream region of the clones. Primer set C, with the primers 
5GFPMYC and 3GFP1940, was designed to amplify 700-bp is also shown.
B. Image of an agarose gel that resolved the PCR product. The set of primers are labeled 
on top of the name of the parasite strain tested. The expected band migrated at ~500-bp 
when primer set A was used and ~600-bp when primer set B was used. Genomic DNA 
was used as a template from wild type (PLKAHX) and transgenic strains i.e. 
mycHisGFP-HX (GFP), 5 'UTRGFP-HX (5H), 3'5'UTRGFP-HX (35C) and 3 'UTRGFP- 
HX (3B) respectively. Parent plasmid p3'5 'UTRGFP-HX (p35GFP) was used as a 
positive control for the PCR for both primer sets.
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3.1.2 Expression profile of GFP under the control of upstream and 
downstream regions of LDH1
In order to evaluate whether the GFP reporter system is being expressed under the 
control of LDH1 upstream and downstream sequences, a western blot analysis was 
performed using polyclonal antibody raised against GFP. Protein lysates were prepared 
from wild type PLF1AHX (negative control), and transgenic control (mycHisGFP-HX) 
and transgenic tests (5'UTRGFP-HX, 3'5'UTRGFP-HX, and 3 'UTRGFP-HX). Equal 
amounts of protein extracts from each strain were analyzed by immunobloting and 
incubated with affinity purified antibody specific to GFP. Another parasite strain 
(HEDL), which constitutively expresses GFP fusion protein was used as positive control 
in early experiments (Figure 3.2 A). Low GFP expression was observed in all transgenic 
tests as compared to that of transgenic control (Tub8mycHisGFP-HX). Negative control 
PLHAHX did not show any GFP band, as expected. In addition, no band was detected in 
protein samples from HFF host cells as shown in Figure 3.2 B. Size of the GFP band 
showed approximately at 57 kDa while the expected GFP band has 35 kDa molecular 
weight.
In order to compare GFP expression with native LDH1, the same blot was 
stripped and western blot was performed using antibody against LDH1. LDH1 with a 
molecular weight of 35 kDa gave very prominent band in each parasite strain tested 
indicating that the amount of protein loaded was equal in each lane and the difference in 
GFP expression observed in transgenic tests could be due to the difference in promoter 
and downstream sequences.
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Figure 3.2
Expression profile of GFP under upstream and downstream region of LDH1
Legends
Images of three different western blot analyses are shown.
A. Upper panel shows GFP expression performed on wild type (PLHAHX), transgenic 
positive control i.e. mycHisGFP-HX (GFP), test strain 35UTRGFP-HX (35C) and 
another parasite strain HEDL that expresses a GFP fusion protein and was used as 
positive control for the experiment. HEDL and transgenic control mycHisGFP-HX 
showed prominent bands. Transgenic test, 35C however did not show any band. Lower 
panel is showing the expression of LDH1 in the same strains when equal amount (20pg) 
of protein was probed with anti LDH1 antibody. All the strains gave strong LDH1 bands 
at 37kDa.
B. Upper panel shows GFP band appeared at 57 kDa when negative control (PLKAHX), 
transgenic positive control mycHisGFP-HX (GFP), and three transgenic test strains 
5UTRGFP-HX (5H), 35UTRGFP-HX (35C), and 3UTRGFP-HX (3B) were probed with 
anti-GFP antibody. Protein lysates from host HFF were also subjected to western blot 
analysis to rule out the possibility of antibody cross reaction with host proteins. 
Transgenic positive control gave very prominent bands as compare to the three transgenic 
test strains. Negative control and HFF did not show any bands. Lower panel shows LDH1 
expression in all the strains tested.
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3.1.3 mRNA levels
In order to determine the level of mRNA among transgenic test strains and to 
compare it with the wild type, RNA was isolated from wild type and transgenic strains 
and reverse transcription was performed. In order to check the quality of cDNA, the 
resulting RT product from transgenic control mycHisGFP-HX (GFP) was subjected to 
PCR using primer set C and another primer set LDH (sense and antisense). Primer set 
LDH was able to amplify DNA from the complimentary DNA of mycHisGFP-HX (GFP) 
while primer set C did not produce any band from the same cDNA template. Plasmid 
pmycLDHl(pmycLl) was used as a positive control for the PCR reaction using the same 
primer LDH. Several attempts were made but did not work. Another primer set 
5'T7GFPmut2 and 3'T7GFPmut was also tested with the genomic DNA from wild type 
and transgenic tests, but a non specific band appeared (data not shown here). This band 
appeared with genomic DNA from RHAHX also. Thus primer set C could not be used for 
PCR from cDNA of transgenic Control.
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Figure 3.3
Measurement of mRNA level
Legend
Image of an agarose gel showing RT-PCR from wild type (PLKAHX), 
mycHisGFP-HX (GFP), and 3UTRGFP-HX (3B) strains. Primer set C and primer LDH 
were used. Primer set LDH successfully amplified 300-bp band from mycHisGFP-HX 
cDNA. No product was made using primer set C.
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PCR RT-PCR
Primer set C
pmycLl PLK GFP 3B
PCR RT-PCR
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730-bp
300-bp
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3.1.4 Localization of GFP gene product
In order to determine whether the GFP reporter was expressed in a similar fashion 
as that of LDH 1, levels of GFP expression were monitored by immunofluorescence and 
its subcellular localization was determined using immunolocalization in both stages of 
parasite life cycle (Figure 3.4). Transgenic parasite strains, as well as the wild type 
(PLKAHX) were subjected to immunofluorescence assay using GFP-specific polyclonal 
antisera raised in goats. A rhodamine conjugated secondary antibody was used to reveal 
the abundance and location of GFP since a direct green fluorescence from the transgenic 
strains could not be detected. Nuclear staining was performed using DAPI. When merged 
to DAPI images, Rhodamine signals were limited to cytoplasm indicating that GFP has a 
cytoplasmic localization.
3.1.4.1 GFP localization in tachyzoites
In order to estimate the abundance of GFP among the three test transgenic 
parasite lines as compared to the transgenic positive control and that of wild type, DAPI 
was used as an internal control. Intensities of rhodamine fluorescence signals and that of 
DAPI were quantified. The relative fluorescence was determined by the ratio of GFP 
signals with reference to DAPI signals. The positive control and the three test strains 
showed GFP in more or less same amount. The negative control showed some 
background noise signals.
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Figure 3.4
Localization of GFP in Tachyzoites
Legend
A. Immunofluorescence assay performed with transgenic and wild type parasites in 
tachyzoite stage. Phase contrast micrographs are shown in upper panel and those of 
immunofluorescence labeling in the lower panels. DAPI was used to label nucleus of 
human foreskin fibroblasts and of parasites. Rhodamine-labeled sheep anti-goat IgG 
was used to reveal the immunoreactive protein recognized by anti-GFP. All 
transgenic strains showed cytoplasm localization of GFP when compared with 
nuclear staining by DAPI.
B. GFP fluorescence measured and recorded by the software provided with the 
microscope. GFP levels were compared with that of DAPI as an internal control is 
shown in graphical form. Level of GFP expression is approximately the same in all 
transgenic strains. The negative control also showed some noise signals. The error 
bars are representing standard deviation.
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3.1.4.2 GFP localization in bradyzoites
In order to determine the effect of upstream and downstream regions of LDH1 on 
GFP expression during bradyzoite stage, the tachyzoites were switched to bradyzoite. 
The differentiation was done by changing EDI medium to RPMI and growing the 
parasites in low CO2 environment. Once the parasite switches to bradyzoites they form a 
cyst around them and the rate of parasite replication slows down. Parasite metabolism 
changes with the differentiation and instead of LDH1, the parasite now expresses LDH2, 
even though the mRNA of LDH1 is reported to be found in both stages. Fluorescein 
isothiocyanate (FITC)-conjugated Dolichos biflorus lectin that specifically binds to the 
N-acetylgalactosamine moiety within the cyst wall was used as a marker for cyst wall 
development (Tomavo, 2001). FITC conjugated Dolichos biflorus lectin was used to stain 
the cyst wall and as an indicator of bradyzoite differentiation. RJhodamine-labeled sheep 
anti-goat IgG was used to reveal the immunoreactive protein recognized by anti-GFP. 
Localization and abundance of GFP was monitored, along with the presence of cyst wall. 
DAPI was used again as an internal control to stain the nuclei (Figure 3.5). GFP levels 
were found decreased with the bradyzoite differentiation.
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Figure 3.5
Localization of GFP in bradyzoites
Legend
A. Immunofluorescence assay performed with PLKAHX and all the transgenic strains. 
Phase contrast micrographs are shown in upper panel and those of immunofluorescence 
labeling in the lower panels. Nuclear staining was done by DAPI, shown in panel 2, and 
was used as internal control for GFP expression and cyst wall staining. Cyst wall 
development was measured and shown in panel 3. GFP localization and abundance was 
measured by the rhodamine conjugated anti-GFP and shown in the last panel. Transgenic 
strains showed a lowered level of GFP expression but comparatively high levels of N- 
acetylgalactoseamine that served as an indicator of cyst wall development. Rhodamine 
fluorescence as a measure of GFP expression and FITC fluorescence as a measure of N- 
acetylgalactoseamine expression were compared with that of DAPI as an internal control 
to calculate the relative fluorescence units (RFU). Fluorescence was measured and 
recorded by the software provided with the microscope. Level of GFP expression was 
approximately the same in all transgenic strains and was much lower when compared to 
the N-acetylgalactoseamine expression.
B.. Comparison of GFP levels (RFU values) in both stages is shown in graphical form. 
GFP levels were decreased significantly in all transgenic strains when tachyzoites were 
switched to bradyzoites. The negative control (PLKAHX) also showed noise signals for 
GFP expression. Error bars are showing standard deviation.
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3.1.5 Growth Assay:
In order to determine the effect of plasmid insertion on parasite growth, 
infectivity and growth of transgenic parasite strains was determined by 
performing plaque assay. Equal number of parasites (4-5 x 104) was inoculated 
and allowed to grow undisturbed for 8-10 days. Then number of plaques formed 
were counted and are shown in Figure 3.6. Since parasite invasion is coupled with 
its infectivity, the number of plaques formed is taken as a measure of parasite 
growth.
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Figure 3.6
Measurement of growth
Legend
Number of plaques formed by each parasite strain is shown in graphical 
form. Wild type and transgenic strains were allowed to grow for 8-10 days. 
Growth rate is almost similar in all strains showing that plasmid insertion did not 
affect the growth rate of the parasites. The error bars represent standard deviation.
Growth Assay
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3.2 Transcriptional regulation of LDH2
Two transgenic parasite lines were generated to study transcriptional regulation of 
LDH2 in tachyzoites. These transgenic strains were named mycLDHl-HX and 
mycLDH2-HX respectively. Parasite strain mycHisGFP-HX served as negative control 
for the study.
3.2.1 Confirmation of transgene integration
To determine that the LDH1/LDH2 was integrated into the genome of the 
transgenic parasites, PCR analysis was performed using genomic DNA as the starting 
material. In order to amplify a specific segment of the reporter system, different pair of 
PCR primers were designed (Figure 3.7 A). The parasite has genomic LDH1 and LDH2 
also, but both of them have an intron at same relative position and approximately of the 
same size i.e. 538-nucleotides in LDH1 and 588 nucleotides in LDH2. This fact was 
exploited to differentiate between transgenic and native LDH1 and LDH2 expression. In 
order to confirm the transgenic LDH1 expression and differentiate it from the native 
LDH1, primer set D was used. Transgenic parasite line produced both 300 and 837-bp 
band when subjected to PCR amplification. PLKAHX and mycGFP-HX could only give 
837-bp band but not the 300-bp band, which further confirms the specificity of the 
primers (Figure 3.7 B).
For the confirmation of mycLDH2 clones, primer set E was used that amplifies a 
480-bp band from the ORF of transgenic LDH2. The two transgenic test strains have both 
genomic and transgenic LDH2 and produced both the bands when subjected to PCR 
amplification. On the other hand, PLKAHX, being a negative control could amplify only
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1067-bp band but not the 480-bp band further confirming the specificity of these primers. 
Plasmids pmycLDHl and pmycLDH2 were used as a positive control and gave very 
intense bands when used with primer set for LDH1 and LDH2 respectively (Figure 3.7 
B).
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Figure 3.7
Confirmation of transgene integration
Legend
A. Schematic presentation of primer design. Two different set of primers were designed 
for clone confirmation. Primer set D was designed to synthesize a 300-bp band using 
LDH1 ORF as template as shown below. Primer set E was designed to amplify a 480-bp 
band using LDH2 ORF as template.
B. Image of an agarose gel resolving PCR product. The set of primers are labeled under 
the name of the parasite strain tested. The expected band migrated at 837-bp in all the 
strains and 300-bp migrated only in transgenic mycLDHl strain, when primer set D was 
used. Similarly the expected band migrated at 1067-bp in all strains and 480-bp band 
migrated only in transgenic mycLDH2 strain when primer set E was used. Plasmid 
pmycLDHl-HX (pLl) and pmycLDH2-HX (pL2) were used as positive control for the 
PCR for primer set D and E respectively. Genomic DNA amplification from wild type 
PLKAHX, transgenic control mycGFP-HX (GFP) and transgenic test strains mycLDHl- 
HX (L1C) and mycLDH2-HX (L2B) are shown in order.
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Figure 3.7
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3.2.2 Confirmation of transgene by restriction digestion
In order to further confirm the transgenic LDH expression, restriction enzymes 
were used. PCR product from transgenic strains and that of wild type were first phenol: 
chloroform extracted and then ethanol precipitated. The respective DNA pellets were 
resuspended in water and used for later digestion reaction.
3.2.2.1 Confirmation of mycLDHl
For the confirmation of mycLDHl, HincII enzyme was used that cuts the 300-bp
tbband amplified from transgenic LDH1 at the 180 nucleotide, resulting into two bands of 
180 and 127-bp. HincII cuts at nucleotide 180 cleaving the 837-bp band amplified from 
genomic LDH1 into 180 and 657 nucleotide bands. Transgenic strain, mycLDHl shows 
both 180-bp and 657-bp bands confirming the presence of transgenic LDH1 in parasites. 
PLKAHX showed only the 657-bp band but not the 180 bp band.
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Figure 3.8
mycLDHl Clone confirmation by restriction digestion
Legend
HincII-digested (D) and undigested (U) samples are shown from the parent plasmid 
pmycLDHl (pLl), transgenic parasite strain mycLDHl (mycLIC) and the negative 
control (PLKAHX). Digestion of 837 nucleotide DNA strand from genomic LDH1 
resulted into 180 and 657 nucleotide bands in both the negative control and the transgenic 
strain. However, 300-bp from transgenic LDH1 was digested into two bands of 180 and 
127 nucleotides transgenic strain.
pLl M mycLIC PLKdHX
HincII DNA amplification from
0 Genomic DNA LDH1
Transgenic DNALDH1
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3.2.2.2 Confirmation of mycLDH2
PstI enzyme was used for the further confirmation of mycLDH2 expression. PstI 
cuts the 500-bp transgenic LDH2 at nucleotide 252 cleaving it into two bands of 
approximately 250-bp size, while the 1087 nucleotide long native LDH2 is cleaved into 
252 nt and 835 nt long DNA strands. PCR product from PLKAHX and mycLDH2-HX, 
using primer set E, was subjected to PstI digestion. 1087-bp native LDH2 from both wild 
type and transgenic strain was cut into 835 and 252bp band. PstI cut 500-bp transgenic 
LDH2 into two bands of approximately 250-bp size. PCR product from parent plasmid 
pmycLDH2 (pL2) was used as positive control for the digestion reaction and 500-bp 
band was cut into 250-bp band as shown in Figure 3.8.
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Figure 3.9
mycLDH2 clone confirmation by restriction digestion
Legend
Pstl-digested (D) and undigested (U) samples are shown under the name of the parasite 
strains i.e. wild type (PLKAHX) and transgenic strain mycLDH2-HX (mycL2B). 1087- 
bp native LDH2 band from both wild type and transgenic strain was digested by PstI and 
the resulting bands migrated at 835 and 250-bp. While 500-bp transgenic LDH2 band 
was digested into 250-bp band. 500-bp PCR product from parent plasmid (pLl) was also 
digested into 250-bp band. PCR product from the parent plasmid pmycLDH2-HX (pL2) 
served as positive control for the digestion reaction.
PstI
pL2 PLKdHX M mycL2B
U D U D U D
500 b.p 
250 b.p
DNA amplification from 
0 Genomic LDH2 
0 Transgenic LDH2
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3.2.3 Expression profile of mycLDHl
In order to examine the expression of the mycLDHl gene product, western blot 
analysis was performed. Equal amounts of protein extracts from PLKAHX, mycLDHl, 
and mycLDH2 were immuno-blotted and incubated with affinity purified antibody 
specific to 6xHis tag. Protein extracts from human foreskin fibroblasts (HFF) were also 
subjected to western blotting to rule out the possibility of cross contamination. A strong 
band was detected in mycLDHl as compared to mycLDH2 at approximately 37kDa. 
However, when the same experiment was repeated after several passages, did not show 
this band using myc-antibody.
Equivalent amounts (10-15pg) of the same protein preparations were subjected to 
western blot analysis using antibody against LDH1 to ensure that comparable amounts of 
cell free lysates were loaded and probed. All of them gave the same intensity band for 
LDH1 at 37kDa.
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Figure 3.10 
mycLDHl expression 
Legend
Images of three different western blots analyses are shown.
A. upper panel shows western blot of the transgenic and wild type parasites using anti- 
His antibody. Two different amounts of mycLDHl were loaded. A strong band appeared 
at 37kDa for mycLDHl strain while a faint band appeared in mycL2 strain. The band 
appeared in PLKAHX was due to overflow of mycLl sample in the adjacent well. The 
protein lysates from host HFF did not show any band. The lower panel shows the 
expression of LDH1 in all these strains when equal amount of protein was loaded and 
probed with anti-LDHl. Equal intensity bands appeared at 37 kDa. No band was detected 
in HFF using either antibody.
B. Western blot that was repeated after several parasite passages (15-20) using anti-His 
antibody. No signals were revealed, however when the same blot was stripped and 
reprobed with anti-LDHl antibody gave prominent bands at 37 kDa showing LDH 
expression.
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CHAPTER 4
DISCUSSION
The differentiation between actively replicating tachyzoites and slowly dividing/ 
encysted bradyzoites plays an important role in the pathogenesis of T. gondii, especially 
in patients with lowered immunity. From the previous studies it has been established that 
T. gondii expresses two distinct lactate dehydrogenases (LDH) at different stages: LDH1 
during tachyzoite and LDH2 during bradyzoite stage (Yang and Parmley, 1997). 
Mechanism of distinct expression is not well understood, however. LDH is an important 
glycolytic enzyme which catalyzes the interconversion of lactate and pyruate using 
NADH as a coenzyme. Under anaerobic conditions when glycolysis becomes the only 
pathway to generate energy, LDH plays an essential role. Yang and Parmely (1997) have 
clearly shown that mRNA for LDH1 is present in both stages but translated only in 
tachyzoites not in the bradyzoites, indicating a translational suppression of LDH1 in 
bradyzoites. On the contrary, mRNA for LDH2 is present only in bradyzoites but not in 
tachyzoites suggesting a transcriptional regulation of LDH2 during this stage. LDH2 
mRNA stability was not measured in this study, hence it is not clear whether high mRNA 
levels are due to an increase in mRNA stability or because of transcriptional activation of 
LDH2 gene. Using a CAT reporter with the putative promoter sequences of LDH1 and 
LDH2 they also demonstrated that in the tachyzoites, CAT expression under LDH1 
promoter sequence was high and reduced four fold with the differentiation to bradyzoites. 
On the other hand no CAT activity was found in tachyzoites when CAT expression was 
under LDH2 promoter control. However, it increased to forty-five fold upon switching to
74
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
bradyzoites. Studies done in other eukaryotic systems also suggest a possible role of 
untranslated regions in gene expression (Park et al., 2001). Regulatory activities of 5' and 
3 ' untranslated regions have been reported in human aggrecan gene where untranslated 
regions exerted differential effects on two different types of promoters (Wilmot et al., 
1998).
4.1 Translational suppression of LDH1
The expression of GFP under the control of upstream and downstream sequence 
o f LDH 1 was determined by western blot analysis. GFP was tagged with ten amino acids 
of myc-epitope and 8x His tag at its amino terminus. Anti-myc antibody and anti-His 
antibody were used in determining GFP expression but signals were not detected (data 
are not shown). A possible reason could be that these short amino acid tags were masked 
by the folding of GFP during translation. However, GFP was detected using the anti-GFP 
antibody, even though the signals were not very strong, especially in transgenic strains, as 
compared to the transgenic control line, mycHisGFP-HX (Figure 3.2). This could be due 
to the low abundance of GFP. The observed low level of GFP could be due to the 
difference in the controlling promoter. TUB8 promoter is a stronger promoter than the 
upstream region of LDH 1 used in 5UTRGFP-HX and 35UTRGFP-HX. Moreover, the 
expression of GFP in the control line could also be controlled by the 3'-UTR isolated 
from the major surface antigen (SAG1). 35UTRGFP-HX and 3UTRGFP-HX that has the 
downstream sequence of LDH 1 also showed low levels of GFP. Attempts were made to 
determine the levels of GFP mRNA by RT-PCR, however these were unsuccessful in 
obtaining any PCR product using primer set C, even though other primer sets worked
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with the cDNA from RT reaction, for example primer set D (Figure 3.3). The primer set 
C (Material and Method, section 2.7.1) was aimed to amplify whole GFP including myc- 
tag. This primer set did not give any PCR product when it was used with genomic DNA 
of transgenic parasites also. A new set of primer should be made aiming to amplify first 
the 350 nt from GFP starting from 1243 nt to 1600 nt in the parent plasmid and can be 
used for both amplifying GFP from genomic DNA and measuring mRNA level from 
cDNA. Northern blot analysis can also be used to determine the mRNA levels of GFP, 
but it requires more starting materials, could be less sensitive than RT-PCR and slight 
degradation of RNA sample would greatly affect the ability to quantitate the mRNA 
expression. Without measuring mRNA level, it is not clear if the lowered GFP expression 
is due to alteration in mRNA stability and subsequent translation. The expected size of 
the band was 37 kDa, while the GFP band was detected at approximately at 57 kDa. This 
band can not be regarded as false positive because it was visible when run along with the 
protein lysates from HEDL strain which expresses a GFP fusion protein. The difference 
in the molecular weight could be due to the readthrough translation of mRNA. Stop 
codon in Colorado tick fever virus (CTFV) has been reported to be a “leaky terminator” 
allowing readthrough translation. As a result truncated termination protein and full length 
readthrough protein are made and serve as structural and non-structural component of the 
virus respectively (Fauziah et al., 2004). There are three stop codons in 3'UTR of SAG1 
at nucleotide position 72, 81 and 135 that could give three different proteins with 
molecular weights 48, 49 and 57 kDa respectively in mycGFP and 5'UTRGFP-HX 
strains. There are four stop codons in 3'UTRLDH1 at nucleotide positions 216, 411, 651 
and 663 which could give three different proteins with the molecular weight 48, 58, and
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70 kDa respectively in 3'UTRGFP-HX and 3 '5 'UTGFP-HX transgenic strains. There are 
different possibilities in case the readthrough occur but why 57 kDa protein appeared in 
particular is debatable.
GFP localization was found to be cytosolic in all transgenic strains, which is in 
accordance with the endogenous LDH that is a cytosolic enzyme. Levels of GFP 
expression among transgenic and control strains during tachyzoite stage were not 
significantly different, even though the control strain showed the highest expression. The 
detection of GFP expression was observed to be better using IFA analysis as compared to 
that of western blot analysis. This could be due to the high sensitivity of detection of IFA 
technique. Negligible amount of noise signals were detected in wild type which could be 
due to the variation in signal recording. The transgenic parasite strains, their respective 
upstream and down stream sequences and the resulting GFP expression and localization 
are shown in tabular on next page. Up arrow indicates an increase and down arrow 
indicates the decrease in intensity of expression of GFP by the detection method used.
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Parasite strain Controlling elements Detection methods
Upstream Downstream WB IFA (Tachy) IFA (Brady)
mycGFP-HX TUB 8 promoter 3UTR SAG1 TTT TTTt II
3UTRGFP-HX TUB 8 promoter
Downstream (794- 
bp)
sequence of LDH1
T TTT II
5UTRGFP-HX
Upstream sequence 
(626-bp) oiLDHl
3UTR SAG1 Tt TTT II
35UTRGFP-HX
Upstream sequence 
(626-bp) of LDH 1
Downstream (794- 
bp)
sequence of LDH1
TT TTT II
GFP expression and localization during tachyzoite stage is the highest in the 
control where the controlling elements are TUB 8 promoter and 3UTR SAG1. The 
intensity of expression was affected when the controlling elements were replaced with 
upstream and/or downstream sequence of LDH 1.
Levels of GFP were found greatly reduced when measured in bradyzoite stage as 
shown in Figure 3.5. Bradyzoite stage resembles to anaerobic condition where parasite 
metabolism is changed significantly to adapt to the surrounding environment. The 
reduction in GFP expression during bradyzoite stage could be due to the upstream and 
downstream region of LDH1. However, from these results it is hard to say that the 
decrease in expression is due to low transcription or low translation. If the level of
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mRNA in all transgenic strains is measured and is found equal, it would clearly establish 
that lowering of expression is occurring at translation level.
Growth rate was found approximately the same in all transgenic strains indicating 
that the plasmid insertion by electroporation does not affect the growth and infectivity of 
the parasites. Growth rate of the wild type was found to be a bit higher as compared to 
the transgenic control and test strains.
4.2 Transcriptional regulation of LDH2
The other two transgenic strains were generated to investigate the transcriptional 
regulation of LDH2 in tachyzoites. PCR analysis from the genomic DNA of transgenic 
parasites showed the presence of transgenes, however it is not clear that if  the transgene 
is integrated into the parasite genome and replicated with the parasite chromosome. The 
plasmid integrates into the genome by homologous recombination which could results in 
random integration, insertional mutagenesis, difference in copy number and silencing of 
the introduced gene or nearby genes by de novo methylation. Western blot analysis was 
performed to determine the expression of ORF of LDHs using anti-His antibody. Strong 
signals were revealed from mycLDHl strain while very faint signal appeared in 
mycLDH2 strain even though both the reporters were under the control of TUB 8 
promoter and should have given constitutive expression. This could be due to difference 
in copy number of the transgene. However, when the same experiment was repeated after 
several parasite passages (15-20), these signals were not detected. Because of the 
selection pressure, only the transformed parasite could survive and the untransformed 
would gradually die with the continued drug selection, even if they have survived during
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first few passages. However, the parasites kept growing but the reporter expression 
vanished i.e. selectable marker is being expressed in the parasites but not the reporter. 
How this partial transgene expression could have happened is difficult to explain in 
T.gondii.
4.3 Future Directions 
Translational suppression
In order to further confirm and clearly establish the role of upstream and down 
stream sequences of LDH1 in translational suppression followings could be done,
1. To quantitate the level of GFP mRNA by RT-PCR to establish that the decrease in 
expression is at translational level.
2. Determining mRNA Stability to rule out the possibility of mRNA being degraded 
before transport to cytosol.
LDH2 misregulation
In order to better understand the transcriptional regulation of LDH2, unregulated 
LDH expression and its effect on parasite phenotype would be monitored. The following 
experiments could be done,
1. To investigate the effect of misregulation, parasites can be inoculated into the mice to 
test their virulence. Characteristic symptoms of the disease will be monitored along with 
their ability to make brain cyst as compared to the control.
2. To monitor if the overexpression of transgenic LDH2 in tachyzoites could force 
parasite encystations, IFA could be done for the detection of cyst wall development.
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3. To differentiate the native LDH1 from myc-tagged transgenic LDH2, antibodies 
against both of them conjugated to different fluorescent probe can be used. Co­
localization of both, if any, can be monitored by doing IFA
4. To determine the effects of transgenic LDH1 during bradyzoite stage, again phenotype 
change can de monitored. To differentiate native LDH2 from myc-tagged transgenic 
LDH1, specific antibodies conjugated to different fluorescent probe can be used. IFA 
can be done to determine if any co-localization exists.
81
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
REFERENCES
Al-Anouti F, Tomavo S, Parmley S, and Ananvoranich S (2004) The expression of 
Lactate dehydrogenase is important for the cell cycle of Toxoplasma gondii. The Journal 
o f Biological Chemistry. 279, 52300-52311
Antequera F, Bird A. (1999) CpG island as genomic footprints of promoters that are 
associated with replication origins. Current Biology. 9, R661-67.
Benecke, A, Gaudon C, and Gronemeyer H (2001) Transcriptional integration of 
hormone and metabolic signals by nuclear receptors. Pp 167-214 in J. Locker, ed 
Transcription factors. Academic Press, San Diego, Calif
Black M and Boothroyd J (1998) Development of a stable episomal shuttle vector for 
Toxoplasma gondii. The Journal o f Biological Chemistry. 273, 3972-3979.
Black M and Boothroyd JC (2000) Lytic cycle of Toxoplasma gondii. Microbiology and 
Molecular Biology Reviews. 64, 607-623.
Blackwood EM, and Kadonaga JT (1998) Going the distance: a current view of enhancer 
action. Science. 281, 61-63.
Bohne, W, Heesemann J, and Gross U (1993) Induction of bradyzoite-specific 
Toxoplasma gondii antigens in gamma interferon-treated mouse macrophages. Infection 
and Immunology. 61, 1141-1145.
Bohne, W, Heesemann J, and Gross U (1994) Reduced replication of Toxoplasma gondii 
is necessary for induction of bradyzoite-specific antigens: a possible role for nitric 
oxidein triggering stage conversion. Infection and Immunology. 62, 1761-1767.
82
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Boothroyd, JC, Black M, Kim K, Pfeferkom ER, Seeber F, Sibley D, and Soldati D. 
(1995) Forward and reverse genetics in the study of the obligate intracellular parasite 
Toxoplasma gondii. Methods in Molecular genetics. 6, 3-29.
Boothroyd JC, Black m, Bonnefoy S, Hehl A, Knoll LJ, Manger ID, Ortega-Barria E, and 
Tomavo S. (1997) Genetic and biochemical analysis of development in Toxoplasma 
gondii. Philosophical Transactions o f the Royal Society London B Biological Sciences. 
352, 1347-1354.
Burg, JL, Perelman, D. Kasper LH. Ware PL. and Boothroyd JC (1988) Molecular 
anlysis of the genes encoding the major surface antigens of Toxoplasm gondii. Journal o f  
Immunolgy. 141,3584-3591.
Carruthers, VB and Sibley LD (1997) Sequential protein secretion from three distinct 
organelles of Toxoplasma gondii accompanies invasion of human fibroblasts. European 
Journal o f Cellular Biology. 73, 114-123.
Casey JL, Hentze MW, Koeller DM, Caughman SW, Rouault TA, klausner RD, and 
Harford JB (1988) Iron-Responsive Elements: Regulatory RNA sequences that control 
mRNA levels and translation. Science. 240, 924-928.
Chen CYA, and Shyu AB (1995) AU-rich elements: characterization and importance in 
mRNA degradation. Trends in Biochemical Sciences. 20, 465-470.
Chu E, Voeller D, Koeller DM, Drake JC, Takimoto CH, Maley GF, Maley F, and 
Allegra CJ (1993) Identification of an RNA binding site for human thymidyl synthase. 
Proceedings o f  National Academy o f Science USA. 90, 517-521.
83
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Cooper JA, Reiss NA, Schwartz RJ, and Hunter T (1983) Three glycolytic enzymes are 
phosphorylated at tyrosine in cells transformed by Rous sarcoma virus. Nature. 302, 218- 
223.
Denton H, Roberts CW, Alexander J, Thong KW, and Coombs GH (1996) Enzymes of 
energy metabolism in the bradyzoites and tachyzoites of Toxoplasma gondii. FEBS 
Micrbiology Letters. 137, 103-118.
Donald RGK, and Roos DS (1993) Stable molecular transformation of Toxoplasma 
gondii: A selectable dihydrofolate reductase-thymidylate synthase marker based on drug 
resistance mutations in malaria. Proceedings o f National Academy o f Science. USA. 90, 
11703-11707.
Donald RGK, and Roos DS (1994) Homologus recombination and gene replacement at 
the dihydrofolate reductase-thymidylate synthase locus in Toxoplasma gondii. Molecular 
and Biochemical Parasitology. 63,243-253.
Donald RG and Roos DS (1995) Insertional mutagenesis and marker rescue in a 
protozoan parasite: cloning of the uracil phosphoribosyltransferase locus from 
Toxoplasma gondii. PNAS. 92, 5749-5753.
Donald RG and Roos DS (1998) Gene knock-outs and allelic replacements in 
Toxolplasma gondii: HXGPRT as selectable marker for hit and run mutagenesis. 
Molecular and Biochemical Parasitology. 91, 295-305.
Donald RGK, Carter D, Ullman B and Roos DS (1996) Insertional tagging, cloning and 
expression of the Toxoplasma gondii Hypoxanthine-Xanthine-Guanine 
Phosphoribosyltransferase gene. The Journal o f Biological Chemistry. 271, 14010-14019.
84
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Dubey JP (1977) Toxoplasma, Hammondia, Besnotia, Sarcocystis, and other tissue cyst- 
forming coccidian of man ans animals, in Parasitic Protozoa (Kreier JP, ed), pp 101- 237. 
New York, Academic press
Dubey JP (1993) Toxoplasma, Neospora, Sarcocystis and otherv tissue cyst forming 
coccidian of humans and animals, second ed, in: J.P.Kreier (Ed.), Parasitic Protozoa, Vol. 
6, Academic Press, San Diego, CA, ppl-158.
Dubey JP (1994) Toxoplasmosis. Journal o f American Veterinary Medicine Association. 
205, 1593-1598.
Dubey JP (1998) Advances in the life cycle of Toxoplasma. International Journal o f 
Parasitology. 28, 1019-1024.
Dubey JP, Linsay DS, Speer CA (1998) structures of Toxoplasma gondii tachyzoites, 
bradyzoites and sporozoites and biology and development of tissue cysts. Clinical 
Microbiology Reviews. 11, 267-299.
Dzierszinski F, Popescu O, Toursel C, Slomiaany C, Yahiaoui B, and Tomavo S. (1999) 
The protozoan parasite Toxoplasma gondii expresses two functional plant-like glycolytic 
enzymes. Implications for evolutionary origin of apicomplexans. The journal o f 
Biological Chemistry. 21 A, 24888-24895.
Endo T, Tokuda H, Yagita K, and Koyama T. (1987) Effects of extracellular potassium 
on acid release and motility initiation in Toxoplasma gondii. Journal o f Protozoolgy. 34, 
291-295.
Endo T and Yagita K (1990) Effects of extracellular ions on motility and cell entry in 
Toxoplasma gondii. Journal o f Protozoology. 37, 133-138
85
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Fauziah MJ, Houssam A, Phillipe DM, Xavier DL (2004) Termination and readthrough 
proteins encoded by genome segment 9 of Colorado tick fever virus. Journal o f General 
Virology. 85, 2273-2244.
Ferguson DJP and Hutchison WM (1987) An ultrastructural study of early development 
and tissue cyst formation of Toxoplasma gondii in the brains in mice. Parasitology 
Research. 73,483-491
Fleming J, Thiele BJ, Chester J, O’Prey J, Janetzki S, Atiken A, Anton I A, Rapoport SM,
and Harrison PR (1989) The complete sequence of the rabbit erytroid cell-specific 15-
lipoxygenase mRNA: comparison of the predicted amino acid sequence of the
erythrocyte lipoxygenase with other lipoxygenases. Gene. 79,181-188
Frenkel JK (1973) Toxoplasmosis. A parasite life cycle, pathology and immunology. In
“The Coccidia” (D. M. Hammond, ed), pp 343-410. University Park Press, Baltimore,
MD.
Freyre A (1995) Separation of Toxoplasma cysts from brain tissue and liberation of 
viable bradyzoites. Journal o f  Parasitology. 81, 1008-1010.
Fulton JD and Spooner DF (1960) Metabolic studies on Toxoplasma gondii. 
Experimental Parasitology. 9, 293-301.
Gazzinelli, RT. Eltoum I, Wynn TA, and Sher A. (1993) Acute cerebral toxoplasmosis is 
induced by in vivo neutralization of TNF-a and correlates with the down-regulated 
expression of inducible nitric oxide synthase and other markers of macrophage activation. 
Journal o f Immunology. 151, 3672-3681.
Geoffrey MC (2000) The Cell A molecular approach. Boston University Second edition 
Sinauer Associates, Inc.
86
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Goodwin EB, Okkema PG, Evans TC and Kimble J (1993) Translational regulation of 
tra-2 by its 3 'untranslated region controls sexual identity in C. elegance. Cell 75, 329- 
339
Gray NK, quick S, Goosen B, Constable A, Hirling H, Kuhn LC, and Hentze MW (1993) 
Recombinant iron-regulatory factor functions as an iron-responsive-element-binding- 
protein, a translational repressor and an aconitase. A functional assay for translational 
repression and direct demonstration of the iron switch. European Journal o f 
Biochemistry. 218, 657-667.
Grunstein M (1997) Histone acetylation in chromatin structure and transcription. Nature. 
389, 349-52.
Guarente L (1999) Diverse and dynamic functions of the Sir silencing complex. Nature 
Genetics. 23, 281-285.
Hanna-Rose W, Hansen U (1996) Active repression mechanisms of eukaryotic
transcription repressors. Trends in Genetics. 12, 229-234
Hentze MW, Caughman SW, Rouault TA, Barriocanal JG, Danics A, Harford JB,
Kasper LH and Ware PL (1985). Recognition and characterization of stage specific 
oocysts/sporozoite antigens of Toxoplasma gondii by human antisera. Journal o f Clinical 
Investigations. 75, 1570.
Hentze MW, Caughman SW, Rouault TA, Barriocanal JG, Danics A, Harford JB, and 
Klausner RD (1987) Identification of the Iron-Responsive element for the translational 
regulation of Human Ferritin. Science. 238, 1570-1573.
87
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Hentze MW, Caughman SW, Casey JL, Koeller DM, Rouault TA, Harford JB, and 
Klausner RD. (1988) A model for the structure and function of iron-responsive element. 
Gene (Amst). 72, 201-208.
Kim K, Soldati D, and Boothroyd JC. (1993) Gene replacement in Toxoplasma gondii 
with chloramphenicol acetyl transferase as selectable marker. Science. 262, 911-914 
Kissinger J, Gajira B, Li L, Paulsen I and Roos D (2003) ToxoDB: accessing the 
Toxoplasma gondii genome. Nucleic Acids Research. 31, 234-237.
Klausner RD (1987) Identification of the iron-responsive element for the translational 
regulation of human ferritin mRNA. Science. 238, 1570-1573.
Klausner RD, Rouault T and Harford JB. (1993) Regulating the fate of mRNA: The 
control of cellular iron metabolism. Cell. 72, 19-28.
Kozak M (1986) Influence of mRNA secondary structure on inhibition of eukaryotic 
ribosome. Proceedings o f National Academy o f Science USA. 83, 2850-2854.
Kozak M (1991) Structural features in eukaryotic mRNAs that modulate the initiation of 
translation. Journal o f  Biological Chemistry. 266, 19867-19870.
Krahenbuhl JL, Remington JS (1982) The immunology of Toxoplasma and 
toxoplasmosis, in Immunology of Parasitic Infections (Cohen S, Warren KS, ed), pp 356- 
421. Oxford, Blackwell Science.
Kuras L and Struhl K (1999) Binding of TBP to promoters in vivo is stimulated by 
activators and requires Pol II holoenzyme. Nature. 399, 609-613
Lawson TG, Rasy BK, Dodds JT, Grifo JA, Abramson RD, Merrick WC, Betsch DF, 
Weith HL, Thach RE (1986) Influence of 5'proximal secondary structure on the
88
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
translational efficiency of eukaryotic mRNA and on their interaction with inhibition 
factors. Journal o f Biological Chemistry. 261, 13979-13989.
Le Cam A, and Legraverend C (1995) Transcriptional repression, a novel function for 3' 
untranslated regions. European Journal o f Biochemistry. 231, 620-627.
Lee TI, and Young RA (2000) Transcription of eukaryotic protein-coding genes. Annual 
Reviews o f  Genetics. 34,77-137
Lemon B and Tijan R (2000) Orchestrated response: a symphony of transcription factors 
for gene control. Genes and development. 14, 2551-2569
Levy S, Avni D, Hariharan N, Perry RP and Meyuhas O (1991) Oligo pyrimidine tract at 
the 5'end of the mammalian ribosomal protein mRNA is required for their translational 
control. Proceedings o f National Academy o f Science USA. 88, 3319-3323.
Luft BJ, Remington JS (1988) A.I.D.S. commentary, Toxoplasmic encephalitis. Journal 
o f Infectious Disease. 157, 1-6.
Luft BJ and Remington JS (1992) Toxoplasmic encephalitis in AIDS. Clinical Infectious 
Disesases 15, 211-222.
Lugar K, Mader AW, Richmond RK, sergeant DF, and Richmond TJ (1974). Crystal 
structure of the nucleosome core particle at 2.8A0 resolution. Nature. 389, 251-260. 
Matsukayashi H and Akao S. (1963) Morphological studies on the development of the 
Toxoplasma cyst. American Journal o f Tropical Medicine and Hygiene. 12, 321-333. 
Mavin S, Joss AW. Ball J, and Ho-Yen Do (2004) Do Toxoplasma gondii RH strain 
tachyzoites evolve during continuous passage? Journal o f Clinical Pathology. 57, 609- 
611.
89
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Melefors O. Goossen B, Johansoon HE, Stripecke R, Gray NK, Hentze MW (1993) 
Translational control of 5-aminolevulinate synthase mRNA by iron-responsive element in 
erythroid cells. Journal o f Biological Chemistry. 268, 5974-5978.
Melo EJT, Carvalho TU, and de Souza W (1992) penetration of Toxoplasma gondii into 
host cells induces changes in the distribution of the mitochondria and the endoplasmic 
reticulum. Cell Structure and Function. 17, 311-317.
Messina M, Niesman I, Mercier C, and Sibley LD (1995) Stable DNA transformation of 
Toxoplasma gondii using phleomycin selection. Gene. 165, 213-217.
Mills J (1986) Pneumocystis carinii and Toxoplasma gondii infections in patients with 
AIDS. Reviews in Infectious Disease. 8; 1001-1011.
Nasmyth K (1996) Viewpoint: putting the cell cycle in order. Science 274, 1643-1645. 
Nicola KG, and Matthias WH (1994). Regulation of protein synthesis by mRNA 
structure. Molecular Biology Reports. 19, 195-200.
Park JH, Kim C, Kim WB, Kim YK, Lee SY, and Yang JM (2001). Removal of 5- and 3- 
untranslated regions enhances erythropoietin gene expression in mammalian cells. 
Molecular Biology. 35(3) 350-353
Pazin MJ, Kadonaga JT (1997) what’s up and down with histone deacetylation and 
transcription? Cell. 89, 325-328.
Perez P, Tiraby G, Kallerhoff J, and Perrel J. (1989) Phleomycin resistance as a dominant 
selectable marker for plant cell transformation. Plant Molecular Biology. 13, 365-373. 
Pfefferkom ER, Pfefferkom LC and Colby ED (1977) Development of gamates and 
oocysts in cats feds systs derived from cloned trophozoites of Toxoplasma gondii. 
Journal Parasitology. 63, 158
90
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Pfefferkom ER (1984) Interferon y-blocks the growth of Toxoplasma gondii in human 
fibroblasts by inducing the host cells to degrade tryptophan. Proceedings o f National 
Academy o f  Science USA.81, 908-912.
Pfefferkom ER, and Borotz SE (1994) Comparison of mutants of Toxoplasma gondii 
selected for resistance to azithromycin, spiramycin or clindamycin. Antimicrob. Agents in 
Chemotherapy. 38, 31-37.
Prikkala L, Nykanen P, and Sistonen L (2001) Roles of the heat shock transcription 
factors in regulation of the heat shock response and beyond. FASEB Journal. 15, 1118- 
1131
Prince JB. Auer KL. Huskinson J. Parmley SF. Araujo FG and Remington JS (1990) 
Cloning, expression and cDNAsequence of surface antigen P22 from Toxoplasma gondii. 
Molecular and Biochemical Parasitology. 43, 97-106.
Radke JR, and White MW (1998) A cell cycle model for the tachyzoite of Toxoplasma 
gondii using the Herpes simplex vims thymidine kinase. Molecular and Biochemical 
Parasitology. 94, 237-247.
Roos D, Donald RGK, Morrissette N, and Moulton ALC (1994) Molecular tools for 
genetic dissection of the protozoan parasite Toxoplasma gondii. Methods in Cell Biology. 
45,27-63.
Sambrook J, Fritsch EF, Maniatis T (1989) Molecular Cloning: A Laboratory Manual, 2nd 
Ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
Sibley LD and Boothroyd JC (1992) Virulent strain of Toxoplasma gondii comprise a 
single clonal lineage. Nature (London). 359, 82.
Sibley LD and Boothroyd JC (1992) Molecular and Biochemical Parasitology 51, 291.
91
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Smith JE (1995) A ubiquitous intracellular parasite: the cellular biology of Toxoplasma 
gondii, International Journal Parasitology. 25, 1301-1309.
Sibley LD, Messina M, and Niesman IR (1994) Stable DNA transformation in the 
obligate intracellular parasite Toxoplasma gondii by complementation of tryptophan 
auxotrophy. Proceedings o f National Academy ofScinece USA. 91, 5508-5512 
Soete M, Fortier B, Camus D, and Dubremetz JF (1993) Toxoplasma gondii: kinetics of 
bradyzoite-tachyzoite interconversion in vitro. Experimental Parasitology. 76, 259-264. 
Soete M, Camus D, and Dubremetz JF (1994) Experimental induction of bradyzoite- 
specific antigen expression and cyst formation by RH strain of Toxoplasma gondii in 
vitro. Experimental Parasitology. 78, 361-370.
Soldati D, Kim K, Kampmeier J, Dubermetz JF, and Boothroyd JC (1995) 
Complementation of Toxoplasma gondii ROP1 knock-out mutant using phleomycin 
selection. Molecular and Biochemical Parasitology. 74, 87-97.
Southard JN, Barrett BA, Bikbulatova L. (1995) Growth hormone (GH) receptor and 
GH-binding protein messenger ribonucleic acid and alternative 5 'untranslated regions are 
differentially expressed in mouse liver and placents. Endocrinology. 136, 2913-2921. 
Spena A, Krause E, and Dobberstein B (1985) Translational efficiency of Zein mRNA is 
reduced by hybrid formation between 5' and 3' untranslated regions. EMBO Journal. 4, 
2153-2158.
Tenant-Flowers M, Boyle MJ, Carey D, Marriot DJ, Harkness JL, Penny R and Cooper 
DA. (1991) Sulphadiazine desensitization in patients with AIDS and cerebral 
toxoplasmosis. AIDS. 5, 311-315.
92
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Tomavo S. Fortier B. Soete M. Ansel C. Camus D. and Dubremetz JF (1991) 
Characterization of bradyzoite specific antigens of Toxoplasma gondii. Infection and 
Immunology. 59, 3750-3753.
Tomavo S. and Boothroyd JC (1995) Interconnection between organellar functions, 
development and drug resistance in the protozoan parasite, Toxoplasma gondii. 
International Journal o f Parasitology. 25, 1293-1298.
Tomavo S. (2001) The differential expression of multiple isoenzyme forms during stage 
conversion of Toxoplasma gondii: an adaptive developmental strategy. International 
Journal o f Parasitology. 31,1023-1031.
Vercesi AE, Rodrigues CO, Uyemura SA, Zhong L, and Moreno SN (1998) Respiration 
and oxidative phosphorylation in the apicomplexan parasite Toxoplasma gondii. Journal 
o f Biological Chemistry. 273, 31040-31047.
Wilmot BV, Glyn DP, Jennifer D, Stuart GF, and Anthony R (1998). Regulatory 
activities of the 5'- and 3 '-untranslated regions and promoter of the human aggrecan 
gene. The Journal o f Biological Chemistry. 273 (11), 6196-6202.
Wolffe AP and Pruss D (1996) Targeting chromatin disruption: Transcription regulators 
that acetylate histones. Cell. 84, 817-819.
Wong SY and Remington JS (1993) Biology of Toxoplasma gondii. AIDS 7, 299-316 
Yang S and Parmely SF. (1995) A bradyzoite stage-specifically expressed gene of 
Toxoplasma gondii encodes a polypeptide homologous to lactate dehydrogenase. 
Molecular and Biochemical parasitology. 73, 291 -294.
93
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Yang S and Parmely SF. (1997) Toxoplasma gondii expresses two distinct lactate 
dehydrogenase homologous genes during its life cycle in intermediate hosts. Gene. 184, 
1-12
94
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
APPENDIX A 
List of Oligonucleotides and plasmids
Primers Sequence
Set A 5PL1 5 'CACACTGGGTAGTGTCC3'
3GFP1491 5' GTCGTGCCGCTTC AT AT G 3 '
Set B 5GFP1667 5' GA AT AC AACTAC AACT CC 3'
3UTRL1 5' CTCATGCTTGCACGCGTT 3 '
SetC 5GFPMYC 5' ATGCAGGAGCAGAAGCTC 3'
3GFP1940 5' GCCATGTGTAATCCCAGC 3'
Set D LDH-ORF sense 5 'ATGGCACCCGCACTGGT3'
LDH-ORF antisense 5' GCGGAAGCGACCAGTCGA 3'
SetE LDH2 forward 5'ATGACGGGTACCGTTAG 3'
LDH2 reverse 5' AAATCGTGCCGAATCTA 3 '
3'LDHPacI 5 'CCCTTAATTAAGTGCCAAGCTTAAGA 3'
5 XDHx Nsil 5' G ATTT C AG A ATT CGG AT CC 3'
BamHI 3'UTR dws 780 
LDH1
5' AAAGGATCCTCTATGTATCATGGGC 3'
PacI 3UTR ups 780LDH1 5' CCCTTAATTAAGCGTTGGCAAAACAGG 3'
Hindlll dws 600 LDH1 5' A AGCTT GCT G ACTA A AAATG AGC 3'
Kpnl ups 600 LDH1 5' CCCGGTACCTGCTGTGCGAATGTGTC 3'
5' T7 GFPmut2 5' AAGAATTGTAATACGACTCACTA 3'
3' T7 GFPmut 5' GTGTCCAAGAATGTTTCC 3'
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Restriction map for control plasmid (pTUB8mycHisGFP-HX)
Sell 523 7
S a c
Ampicillin
T U B Sprom oter
icoR11148
pTUB8inycHisGFP-HX 
6 4 1 8  b p
3UTRSAG1
HXGPRT
Bam HI 2 2 9 4
E co N I4 0 2 5
B sin l 3 6 9 2
Sequence of TUB8 promoter (495-bp)
K pnl (653)
GGTACCGGGC CCCCCCTCGA CGGTATCGAT AAGCTTAACC ACAAACCTTG 
AGACGCGTGT TCCAACCACG CACCCTGACA CGCGTGTTCC AACCACGCAC 
CCTGAGACGC GTGTTCTAAC CACGCACCCT G AG ACGCGT G TTCTAACCAC 
GCACCCTGAG ACGCGTGTTC AA GCTTGCCT GCATTGGGTG CGGTTGGTGA 
TCCTGGTTGG ACCGGTGGAG ATGCGCGCGC ACGAAGGGGA TGTGTCAGAA 
ACATTTTGTT TGTTCTCTGT GAACTTTTAG ATGTGTTAAA GGCGGCGAAT 
ATTAGCAGAG AGTCCTCCTT GTTCCATTCT CTCTTGAATT TCGCCCTTTC 
CTTCTCTTTG CGAGTGTGGT AGAGAACAAG CACTCGTTCG CCGTCCCTGA 
CGACGCAACC CGCGCAGAAG ACATCCACCA AACGGTGTTA CACAATCACC 
TTGTGTGAAG TTCTTGCGGA AAACTACTCG TTGGCATTTT TTCTTGAATT 
C
EcoRI (1148)
Sequence of myc and His tags (75-bp)
30 nt Myc and 24 nt His tags (in bold) are shown in order.
CCTTTTTCGA CAAAAAATGC AGGAGCAGAA GCTCATCTCC GAGGAGGACC 
TGGCCATGGC CATGCAGCAC CACCATCACC ACCATCACCA T
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Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Sequence of GFP (734-bp)
Nsil (1243)
ATGCATAGTA AAGGAGAAGA ACTTTTCACT GGAGTTGTCC CAATTCTTGT 
TGAATTAGAT GGTGATGTTA ATGGGCACAA ATTTTCTGTC AGTGGAGAGG 
GTGAAGGTGA TGCAACATAC GG A A A ACTT A CCCTTAAATT TATTTGCACT 
ACTGGAAAAC TACCTGTTCC ATGGCCAACA CTTGTCACTA CTTTCTCTTA 
TGGTGTTCAA TGCTTTTCAA GATACCCAGA TCATATGAAG CGGCACGACT 
TCTTCAAGAG CGCCATGCCT GAGGGATACG TGCAGGAGAG GACCATCTTC 
TTCAAGGACG ACGGGAACTA CAAGACACGT GCTGAAGTCA AGTTTGAGGG 
AGACACCCTC GTCAACAGGA TCGAGCTTAA GGGAATCGAT TTCAAGGAGG 
ACGGAAACAT CCTCGGCCAC AAGTTGGAAT ACAACTACAA CTCCCACAAC 
GTATACATCA TGGCCGACAA GCAAAAGAAC GGCATCAAAG CCAACTTCAA
GACCCGCCAC AACATCGAAG ACGGCGGCGT GCAACTCGCT GATCATTATC
AACAAAATAC TCCAATTGGC GATGGCCCTG TCCTTTTACC AGACAACCAT
TACCTGTCCA CACAATCTGC CCTTTCGAAA GATCCCAACG AAAAGAGAGA 
CCACATGGTC CTTCTTGAGT TTGTAACAGC TGCTGGGATT AC AC AT GGC A
TGGATGAACT AT AC A A AGCT GCAGATGGTG CTTAA
PacI (1974) continued...
Sequence of 3UTR SAG1 (320-bp)
PacI (1974)
TTAATCACCG TTGTGCTCAC TTCTCAAATC GACAAAGGAA ACACACTTCG 
TGCAGCATGT GCCCCATTAT AAAGAAACTG AGTTGTTCCG CTGTGGCTTG 
CAGGTGTCAC AT CC AC AA AA ACCGGCCGAC TCTAAATAGG AGTGTTTCGC 
AGCAAGCAGC GAAAGTTTAT GACTGGGTCC GAATCTCTGA ACGGATGTGT 
GGCGGACCTG GCTGATGTTG ATCGCCGTCG ACACACGCGC CACATGGGTC 
A AT AC AC AAG ACAGCTATCA GTTGTTTTAG TCGAACCGGT TAACACAATT 
CTTGCCCCCC CGAGGGGGGA TCC
BamH I (2294)
Sequence of HXGPRT
ATGGCGTCCA AACCCATTGA AGACTACGGC AAGGGCAAGG GCCGTATTGA 
GCCCATGTAT ATCCCCGACA ACACCTTCTA CAACGCTGAT GACTTTCTTG 
TGCCCCCCCA CTGCAAGCCC TACATTGACA AAATCCTCCT CCCTGGTGGA 
TTGGTCAAGG ACAGAGTTGA GAAGTTGGCG TATGACATCC ACAGAACTTA 
CTTCGGCGAG GAGTTGCACA TCATTT GCAT CCTGAAAGGC TCTCGCGGCT 
TCTTCAACCT TCTGATCGAC TACCTTGCCA CCATACAGAA GTACAGTGGT 
CGTGAGTCCA GCGTGCCCCC CTTCTTCGAG CACTATGTCC GCCTGAAGTC 
CTACCAGAAC GACAACAGCA CAGGCCAGCT CACCGTCTTG AGCGACGACT 
TGTCAATCTT TCGCGACAAG CACGTTCTGA TTGTTGAGGA CATCGTCGAC 
ACCGGTTTCA CCCTCACCGA GTTCGGTGAG CGCCTGAAAG CCGTCGGTCC
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CAAGTCGATG AGAATCGCCA CCCTCGTCGA GAAGCGCACA GATCGCTCCA
ACAGCTTGAA GGGCGACTTC GTCGGCTTCA GCATTGAAGA CGTCTGGATC
GTTGGTTGCT GCTACGACTT CAACGAGATG TTCCGCGACT TCGAGCACGT
CGCCGTCCTG AGCGACGCCG CTCGCAAAAA GTTCGAGAAG TAA
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Restriction map for plasmid p5UTRGFP-HX
PromoterllTRLDH 1
|)5UTRLDH 1GFP-HX 
6549 bp
GFP
3UTRSAG1
HXGPRT
Upstream sequence of LDH1 (629-bp)
(Kpnl was introduced at 5' primer and Hindlll was introduced on 3 'primer. Hindll was made 
blunt for cloning)
CCTGCTGTGC GAATGTGTgG CGTCGTTTAA AAACTGAACG TGGAAACCGT
TTTCGTGCGA TCCCAGTTAC TCGGCGGCGT CTGAAGTGTG TCCCTCTTCT
CCACTTCAAG ACTGGGACGG GAACGAGAGT TGGACGACCA CTGGAAGCGG
GCGCTCGAAT TTTCTAAAGT TGGCCTCGGG TGTTCGTCCG GTATCTCGCA
GCAGATGACG CAGCACTCCC CGCTGTTTAA GGAACTGGAA TCTTGAACTG
TGCCCCTCTA ACATCGCACC GTCTCTGCGC ACCGTCGCTG TTCCGCGACT
CCCGTCAGAG CGATATCGCG TTGCGTCACG TCATCGTTAT TCGGTTTTTG
TTCGGGAAAA TGGCAGCAGC GGGACGAACA CACTGGGTAG TGTCCACGCC
GCTTCCGTCC CACCTGCGAA GGTGCGTCCA CCACAACTCA CGCGACTAGG
TGCTGCGGCT GCGAATTCGC GTTCCCACAC TCGACCAGAT TTTTTTGATT
TTCGATTTCC AAACGCGATT TATTCCAATC CGCCTTGTAG CAGACTAACC
GGTGCACTTT TGCACGTGTA CGCAAGACAG CTTCGCAGAC AACATCTGGC
AGCCTCCCGC TCATTTTTAG TCAGCAAAA 
<----------------------------------------------------
99
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Restriction map for plasmid p3UTRGFP-HX
Ampicillin
I1IVC x
H is1
p3UTRLDH 1GFP-HX 
6 8 9 2 1>|) GFP
3UTRLDH1
HXGPRT
Downstream sequence of LDHl (796-BP)
(PacI was introduced on 5 'primer and BamHI was introduced on 3 'primer for cloning)
CGTTGGCAAA ACAGpAGCGG AATGCCACTT TACTGCGCGG GGCCCATGAT
TTATACACGC GTTTGCAACG GAAGCGAAAA GACGGTTCCG GTTCGCACCA
CGCGCTCGTC CCGAAAAAGG GAAGTCGCGG CGCTGTCGGT CAACGCTGTG
CGGGTTGCAG GTGCGTGCTT AAGCATCACA AAGTGGCAGA GCCATTTTGT
CCAGGGAAGT AGCGTCTCAA ACAGGTGAAC GCGTGCAAGC ATGAGAGGCA
TCCGTCGCTG CGTTCGCTCA CATATCCGAA GGCAACAGAT TTTGGTCGGC
AAAAGCCTCT GCACAACCGT GGCAAGATGA TGGAAACAGT TCGTGTTTGG 
ACAGCAACCG CGTTCGCTCT CACTCAAAAC CCTGTAGTCG AGAGGGGTGT 
CGCATGACTT GGCTTTTGTG GGAGTGCCCA AATCGTCTGT GTTCGAGGTG 
A AG AT C AC AT GTCCGCTGCA GT ACTGAAA A ACACTTGGTG CGCAGAGGCG 
AGCGATAGGT GCGCTGACTT TTTTTTTGTT TGTTCAAGGA AGGCATCTTT 
TTTTTTTTAC CGGTTGTCCA CTGTCATGTC GAAAACGTAG TCCGTGTGAA 
GTGGTTGGTC CCCTGTTGTC CTT TGTCTAG CCGCGCGTGT CTCATGGAGC 
ATTTTTCAAC GTTGCTTCAA ACGAATGCTG GTTTCTCGAG TGCACCTGCA 
CCGAAAGCTG CGGGAAATTC AAAATCTTTC CCGACAATGC GGAGCCGTAC 
GAAAGCCGAC GTGGGTTATT TGGQXA TG A  TACATAGAGG AACTGG
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Restriction map for plasmid p35UTRGFP-HX
Ampicillin
PromoterUTRLDH 1
myc'
His
|>35UTRLDH1GFP-HX 
7023 bp
GFP
3UTRLDH1
HXGPRT
Upstream sequence of LDH1 (629-bp)
(Primer 5PL1 is highlighted and was used for clone confirmation)
CCTGCTGTGC GAATGTGTCG CGTCGTTTAA AAACTGAACG TGGAAACCGT 
TTTCGTGCGA TCCCAGTTAC TCGGCGGCGT CTGAAGTGTG TCCCTCTTCT 
CCACTTCAAG ACTGGGACGG GAACGAGAGT TGGACGACCA CTGGAAGCGG 
GCGCTCGAAT TTTCTAAAGT TGGCCTCGGG TGTTCGTCCG GTATCTCGCA 
GCAGATGACG CAGCACTCCC CGCTGTTTAA GGAACTGGAA TCTTGAACTG 
TGCCCCTCTA ACATCGCACC GTCTCTGCGC ACCGTCGCTG TTCCGCGACT 
CCCGTCAGAG CGATATCGCG TTGCGTCACG TCATCGTTAT TCGGTTTTTG 
TTCGGGAAAA TGGCAGCAGC GGGACGAACA CACTGGGTAG TGTCCACGCC 
GCTTCCGTCC CACCTGCGAA GGTGCGTCCA CCACAACTCA CGCCxACTAGG 
TGCTGCGGCT GCGAATTCGC GTTCCCACAC TCGACCAGAT TTTTTTGATT 
TTCGATTTCC AAACGCGATT TATTCCAATC CGCCTTGTAG CAGACTAACC 
GGTGCACTTT TGCACGTGTA CGCAAGACAG CTTCGCAGAC AACATCTGGC 
AGCCTCCCGC TCATTTTTAG TCAGCAAAA
Sequence of myc and His tags
(Primer 5GFPmyc is highlighted)
AATGCAGGAG CAGAAGC^CA TCTCCGAGGA GGACCTGGCC ATGGCCATGC 
AGCACCACCA TCACCACCAT CACCAT
Sequence of GFP (734-bp)
(Primer 3GFP1491, 5GFP1667, and 3GFP1940 are highlighted in order. All were used for clone 
confirmation)
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ATGCATAGTA AAGGAGAAGA ACTTTTCACT GGAGTTGTCC CAATTCTTGT 
TGAATTAGAT GGTGATGTTA ATGGGCACAA ATTTTCTGTC AGTGGAGAGG 
GTGAAGGTGA TGCAACATAC GGAAAACTTA CCCTTAAATT TATTTGCACT 
ACTGGAAAAC TACCTGTTCC ATGGCCAACA CTTGTCACTA CTTTCTCTTA 
TGGTGTTCAA TGCTTTTCAA GATACCCAGA TCATATGAAG CGGCACGACT 
TCTTCAAGAG CGCCATGCCT GAGGGATACG T<j CAGGAGAG GACCATCTTC 
TTCAAGGACG ACGGGAACT A CAAGACACGT GCTGAAGTCA AGTTTGAGGG
AGACACCCTC GTCAACAGGA TCGAGCTTAA GGGAATCGAT TTCAAGGAGG
ACGGAAACAT CCTCGGCCAC AAGTTGGAAT AC A ACT AC AA CTCCCACAAC
GTATACATCA TGGCCGACAA GCAAAAGAAC GGCATCAAAG CCAACTTCAa
GACCCGCCAC AACATCGAAG ACGGCGGCGT GCAACTCGCT GATCATTATC 
AACAAAATAC TCCAATTGGC GATGGCCCTG TCCTTTTACC AGACAACCAT
TACCTGTCCA CACAATCTGC CCTTTCGAAA GATCCCAACG AAAAGAGAGA
CCACATGGTC CTTCTTGAGT TTGTAACAGC TGCTGGGATT ACACATGGCA
TGGATGAACT ATACAAAGCT GCAGATGGTG CTTAA ^-------------------------------
Downstream sequence of LDH1 (796-BP)
(Primer 3UTRLlis highlighted and was used for clone confirmation)
CGTTGGCAAA ACAGGAGCGG AATGCCACTT TACTGCGCGG GGCCCATGAT
TTATACACGC GTTTGCAACG GAAGCGAAAA GACGGTTCCG GTTCGCACCA
CGCGCTCGTC CCGAAAAAGG GAAGTCGCGG CGCTGTCGGT CAACGCTGTG
CGGGTTGCAG GTGCGTGCTT AAGCATCACA AAGTGGCAGA GCCATTTTGT
CCAGGGAAGT AGCGTCTCAA ACAGGTG^AC GCGTGCAAGC. ATGAGAGGCA
TCCGTCGCTG CGTTCGCTCA CATATCCGAA GGCAACAGAT TTTGGTCGGC
AAAAGCCTCT GCACAACCGT GGCAAGATGA TGGAAACAGT TCGTGTTTGG
ACAGCAACCG CGTTCGCTCT CACTCAAAAC CCTGTAGTCG AGAGGGGTGT 
CGCATGACTT GGCTTTTGTG GGAGTGCCCA AATCGTCTGT GTTCGAGGTG 
AAGATCACAT GTCCGCTGCA GTACTGAAAA ACACTTGGTG CGCAGAGGCG 
AGCGATAGGT GCGCTGACTT TTTTTTTGTT TGTTCAAGGA AGGCATCTTT 
TTTTTTTTAC CGGTTGTCCA CTGTCATGTC GAAAACGTAG TCCGTGTGAA 
GTGGTTGGTC CCCTGTTGTC CTT TGTCTAG CCGCGCGTGT CTCATGGAGC 
ATTTTTCAAC GTTGCTTCAA ACGAATGCTG GTTTCTCGAG TGCACCTGCA 
CCGAAAGCTG CGGGAAATTC AAAATCTTTC CCGACAATGC GGAGCCGTAC 
GAAAGCCGAC GTGGGTTATT TGGCCCATGA TACATAGAGG AACTGG
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Restriction map for plasmid pmycLDHl-HX
TUBSprinoter
m yc 
His t
|)TUB8mycHisLDH1-HX 
6674 bp
LDH1
3UTRSAG1
HXGPRT
ORF of LDH1 (GenBank accession number U35118)
The LDH1 cDNA (990 nt) fragment was cloned at Nsil and PacI sites.
Primers LDHORF sense and LDHORF antisense are highlighted and were used for clone 
confirmation
 ►
1 2 1  CCGCTCATTT TTAGTCAGCA AAAATGGCAC CCGCACTTGT GCAGAGGAGA AAGAAGGTGG
1 8 1  CCATGATTGG CTCTGGCATG ATTGGTGGCA CTATGGGCTA CCTGTGCGCT CTCCGTGAGC
2 4 1  TCGCTGACGT CGTTCTCTAC GATGTTGTCA AAGGTATGCC CGAGGGTAAG GCTCTTGACC
3 0 1  TGAGCCATGT GACCTCCGTG GTCGACACCA ACGTTTCCGT CCGTGCTGAG ACTCTTACG
3 6 1  AGGCCGCGCT CACCGGTGCG GACTGCGTTA TCGTTACCGC CGGTCTGACC AGGTGCCGG
4 2 1  GCAAGCCCGA CTCCGAGTGG AGCCGAAACG ATCTGCTCCC GTTCAACTCG AGATCATTC
4 8 1  GCGAGATCGG TCA&AACATC AAGAAGTACT GCCCCAAGAC CTTCATCATC TGGTCACCA
5 4 1  ACCCGCTGGA CTGCATGGTC AAGGTTATGT GCGAGGCCTC TGGCGTCCCG CCAACATGA
6 0 1  TCTGCGGTAT GGCCTGCATG CTCGACTCTG GTCGCTTCCG CCGATACGTC CCGACGCGC
6 6 1  TGTCTGTCTC TCCCCGCGAC GTCCAGGCCA CCGTCATCGG CACACACGGC ACTGCATGG
7 2 1  TCCCGCTTGT CCGGTACATT ACCGTGAACG GCTACCCGAT CCAGAAGTTC TCAAGGACG
7 8 1  GCGTAGTCAC GGAGAAGCAG CTCGAGGAGA TCGCTGAGCA CACCAAAGTG CTGGCGGCG
8 4 1  AGATCGTCCG CTTCCTCGGC CAGGGTTCCG CTTACTACGC CCCCGCCGCA CCGCTGTCG
9 0 1  CCATGGCAAC ATCCTTCTTG AACGACGAAA AGCGCGTCAT CCCGTGCAGT TGTACTGCA
9 6 1  ACGGAGAGTA CGGCTTGAAG GACATGTTCA TTGGTCTCCC GGCCGTCATT GAGGCGCCG
1 0 2 1  GCATCGAGCG CGTCATCGAG CTCGAGCTGA ACGAGGAGGA GAAGAAGCAG TCCAGAAGT
1 0 8 1  CCGTCGACGA CGTCATGGCG CTCAACAAGG CGGTTGCTGC TCTTCAGGCG AAGCGTTGG
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Restriction map for plasmid pmycLDH2-HX
Ampicillin
|)TUB8niycHisLDH2-HX 
6665 bp
LDH2
3UTRSAG1
ORF of LDH2 (GenBank accession number U23207)
The LDH2 cDNA (981 nt) fragment was cloned in place of GFP.
Primers LDH2 forward and LDH2rewerse are highlighted and were used for clone confirmation.
2 4 1 TGCTCGGCAT TCGTACTTCA
3 0 1 TGCAATGATT GGTTCTGGCA
3 6 1 GCTAGCCGAC GTCGTACTAT
4 2 1 TGATTCACAG GCGACAAGCA
4 8 1 TGAGAAGATC GCCGGATCGG
5 4 1 GAAGAGTGAC AAGGAGTGGA
6 0 1 AGAGGTAGCG CAGGGAGTGA
6 6 1 CCCGCTTGAC TGCATGGTAA
7 2 1 TTGCGGAATG GCGAATGTGT
7 8 1 GGAGATATCA CCTCGAGATA
8 4 1 GCCTCTCGCG CGTTATGTGA
9 0 1 AAAAATGACT GAGGCAAAAC
9 6 1 GATTGTGAGA CTTTTGGGGC
1 0 2 1 AATGGCCCAG GCATTCTTAA
1 0 8 1 GGGTGAGTAT GGGCTTCACG
1 1 4 1 AATCGAGCAG GTCATCGAAC
1 2 0 1 AGTTGATGAC GTGGTGGAAT
CTTCCACCAT
TGATAGGAGG
TCGACGTTGT
TTGCTGACAC
ATGTCGTAAT
GCAGAAACGA
AGAAGTACTG
AGTGCTTTCA
TAGATTCGGC
GACGGGTACC
AACCATGGGC
AACAGGCATG
GAACGTGAGC
AATAACTGCA
CCTTTTACCG
CCCGCTTGCT
TGAAGCGAGC
ACGATTTAGA
TTCAAGCTAC
CGGTGAGTGG
TGGCAGAGAT
AAGGGTCAGC
AAGACGAGAA
ATATGTTTAT
TGGAGCTGAC
TGAATAAGAG
TGTTATCGGC
TTTCCCACTG
CGTAGAGCGT
GTACTATGCT
GAGAGTGCTC
TGGTTTGCCG
ACATGAGGAA
TTTAGCGGCG
GTTAGCAGAA
TACCTTTGTG
CCAGAAGGGA
GTGACGAGCG
GGGCTGACCA
TTCAATGCAA
TTTGTAATTG
GGGTTACCAA
CGCTTCATTG
ACACACGGTG
CGAGAATTCA
ACAAAGAAAG
CCAGCCCTTT
CCGTGCAGTG
GCAGTTATAG
CAAGAGTGTT
CTGGGTTGAA
AAAAAAGAT
GCTTCGGGA
GGCGTTGGA
AAACCAGTA
GGTACCGGG
AATCATTCG
AGTGACAAA
AAACATGGT
GGATCAGCT
CCACATGCT
TAAAAAAGG
TGGGGGGGA
TGCTATAAC
GTATTGCCA
CGGTGGGGG
CAGGAAGTC
AAGTACGCA
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APPENDIX B
List of Buffers and Solutions
Cytomix Buffer 120mM KC1, 0.15 mM CaCl2, lOmM K2HP04, KH2P 04 
pH7.6, 25mM HEPES pH7.6, EDTA 2mM, MgCl2 
5mM
D-10 medium 10% cosmic calf serum,0.1% antimycotic in DMEM
Dulbecco’s phosphate 
buffered saline (DPBS)
PBS buffer supplemented with 0.1 g/L Ca++
DNA gel loading buffer 0.025% Xyelene Cyanol FF, 0.025% Bromophenol 
Blue, lOmM EDTA pH 8.0 and 98% deinonized 
formamide
Edl medium Eagle’s MEM, l%dFBS, 0.1 %1 antimycotic
HFF freezing medium 25%DMSO, 20% dFBS in DMEM
Lauri Bertani broth (LB broth) lOg/L tryptone, 5g/L yeast extract and 0.17 M NaCl. 
The broth was sterilized by autoclaving for 15 min.
Phosphate-buffered saline 
(PBS)
0.14M NaCl, 2.7 mM KC1, lOmM Na2HP04 and 
1.76mM KH2P 0 4 K2HP04 pH7.4
Protein lysis buffer 50pM HEPES, 5pM PMSF, 0.025% Triton xlOO, 20% 
glycerol
Ponceau S 0.1 % Ponceau in 5% acetic acid solution
Resolving gel 9% acrylamide/bisacrylamide (37.5:1), 0.39 M Tris pH 
8.8, 0.1% SDS, 0.1% APS and 0.04% TEMED
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RPMI1640 50mM HEPES pH8.2, 5% FBS, 20mg antimycotic/L
Running Buffer for protein 
gel
25mM Tris base, 192mM Glycine, 0.037% SDS pH 8.4
SDS-PAGE destaining 
solution
45% methanol and 10% glacial acetic acid (v/v)
SDS-PAGE loading buffer 0.5M Tris-HCl pH 6.8, Glycerol, 14.3M 2- 
merceptoethanol, 10% SDS, 0.05% bromophenol blue.
SDS-PAGE staining solution 2.5g/L Coomassie blue in 40% methanol and 10% 
glacial acetic acid (v/v)
Stripping buffer 0.25 M Glycine pH2.0 and 1% SDS
TBS 200mM NaCl, 20mM Tris pH 7.4
TBST 200mM NaCl, 20mM Tris pH 7.4 and 0.2 % Tween 
(Polyoxyethylene Sorbitan Monolaurate)
T.gondii freezing medium 25% DMSO and 20% dFBS in ED 1
Transfer buffer 25mM Tris base, 192mM Glycine, 20% Methanol (v/v) 
pH 8.4.
Tris EDTA buffer (TE) 10 mM Tris pH 8.0, and ImM EDTA
Tris-Acetate-EDTA (TAE) 40mM Tris-acetate and ImM EDTA
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